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Abstract: Apoptosis is a vital cellular process that is critical for the maintenance of homeostasis in health and disease. The derailment
of apoptotic mechanisms has severe consequences such as abnormal development, cancer, and neurodegenerative diseases. Thus, there
exist complex regulatory mechanisms in eukaryotes to preserve the balance between cell growth and cell death. Initially, proteincoding genes were prioritized in the search for such regulatory macromolecules involved in the regulation of apoptosis. However,
recent genome annotations and transcriptomics studies have uncovered a plethora of regulatory noncoding RNAs that have the ability
to modulate not only apoptosis but also many other biochemical processes in eukaryotes. In this review article, we will cover a brief
summary of apoptosis and detection methods followed by an extensive discussion on microRNAs, circular RNAs, and long noncoding
RNAs in apoptosis.
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1. Introduction
Historically, it was assumed by scientists that cell death
is a natural consequence of life without any genetic basis.
However, the accumulating evidence clearly indicates that
cell death can be intervened both pharmacologically and
genetically, paving the way for its use in health and disease
(Fuchs and Steller, 2015). The Nomenclature Committee on
Cell Death (NCCD) released a report in 2018, proposing
two major cell death modes (1) accidental cell death (ACD)
and (2) regulated cell death (RCD) (Galluzzi et al., 2018).
ACD comes about physico-chemically or mechanically
and, thus, has no application in clinics due to its irreversible
nature. On the other hand, the evolutionarily conserved
and reversible RCD has an essential function in several
key cellular processes such as elimination of excess cells
or life-threatening antigens (Hotchkiss et al., 2009; Chao
et al., 2012; Ouyang et al., 2012; Singh et al., 2012). The
rate of RCD is highly critical in maintaining organismal
homeostasis. Any decline in the rate of cell death may result
in cancer and autoimmune diseases while an elevation in
its rate may lead to neurodegenerative diseases or AIDS.
The cellular function of RCD is not confined to diseases
as it orchestrates numerous physiological processes such
as morphogenesis and organogenesis (Arya and White,
2015).

The first example of programmed cell death (PCD) was
reported in 1965 in a study involving the development of
muscle subsegments (Lockshin and Williams, 1965). The
term apoptosis, which means “falling off ” in Greek, was
then coined in 1972 to describe the characteristics of a
dying cell such as cell shrinkage, chromatin condensation,
nuclear fragmentation, blebbing, and apoptotic bodies
(Kerr et al., 1972). Since the first morphological
description of cell death in 1965, it took nearly 27 years
to characterize an apoptotic protein at the molecular
level (Thornberry et al., 1992). Subsequent studies have
led to the identification of three major types of cell death
although it is sometimes difficult to draw the boundaries
among them unequivocally: apoptosis, autophagy, and
necrosis (Eisenberg-Lerner et al., 2009; Hotchkiss et al.,
2009; Maghsoudi et al., 2012; Berghe et al., 2014; Teng
and Hardwick, 2015). Currently twelve major cell death
subroutines have been characterized in mammals based
on the types of changes in the intracellular or extracellular
microenvironment (Galluzzi et al., 2018).
In this review, we will succinctly describe major
apoptotic pathways followed by the coverage of three
major types of noncoding RNAs (ncRNAs) that modulate
apoptosis, namely microRNAs (miRNAs), circular RNAs
(circRNAs) and long noncoding RNAs (lncRNAs).
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2. Apoptosis
Apoptosis is a type of programmed cell death performed
by activation of a family of cysteine proteases known as
caspases. Apoptosis takes place in an ordered chain reaction
triggered by various intra- or extracellular stimuli such as
ligation of cell surface receptors, treatment with cytotoxic
drugs or irradiation (Blank and Shiloh, 2007). In response
to an apoptotic stimulus, cells exhibit the hallmarks of
apoptosis depicted as shrinkage in cellular volume and
chromatin condensation, which is followed by membrane
blebbing, nucleus fragmentation and, eventually, apoptotic
body formation. These morphological features are cell
type-, stimulus- and apoptotic stage-dependent. During
apoptotic processes, cells, which are defined as apoptotic
bodies henceforth, are rapidly removed from the site of
action through ATP and UTP release, proceeding with
phosphatidylserine presentation for phagocytosis by
macrophages (Nirmala and Lopus, 2020). Maintenance
of plasma membrane integrity prevents the release of the
intracellular content as well as any potential inflammatory
reactions (Elmore, 2007). In case of inefficient removal of
the apoptotic cells, secondary necrosis may arise, leading
to chronic inflammatory diseases such as type 2 diabetes,
atherosclerosis, chronic obstructive pulmonary disease
(COPD), cystic fibrosis, asthma as well as, Parkinson’s,
Alzheimer’s, and Huntington’s disease (Szondy et al.,
2014).
2.1. Pathways of apoptosis
As being committed in a fashion of a cascade of events,
apoptosis proceeds through the phases of initiation,
intracellular response, cell fragmentation, and
phagocytosis (Afford and Randhawa, 2000). Based on
initiator signals and executory processes, the pathways
of apoptosis are classified into three subgroups: extrinsic,
intrinsic, and perforin/granzyme pathways (Figure 1).
First two pathways crosstalk with each other during
caspase activation in the execution phase, and all three
pathways share the same termination module in the end
(Igney and Krammer, 2002).
A specific interaction between a ligand and
transmembrane death receptors, such as tumour necrosis
factor receptor 1 (TNFR1) and Fas receptor (FasR),
which are members of the tumor necrosis factor (TNF)
receptor gene superfamily, initiates apoptosis through
the extrinsic signalling pathway. The ligand-receptor
interaction activates the sequential events of recruitment
of cytosolic adaptor proteins harboring death domains,
death domain association with procaspase-8, formation
of death-inducing signal complex (DISC) and activation
of procaspase-8 to initiator caspase-8. Subsequently,
executioner caspases (caspases‑3, ‑ 6 and ‑ 7) are activated
to complete the process (Blank and Shiloh, 2007; Elmore,
2007).
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The intrinsic pathway is initiated through stress stimuli
such as direct DNA damage, hypoxia, and survival factor
deprivation, and proceeds with the loss of mitochondrial
membrane potential, resulting in an alteration in the
permeability of mitochondria. Cytochrome c is then
released from the intermembrane space into the cytosol
and interacts with proapoptotic cytosolic factor Apaf1 to form the apoptosome, which activates caspase-9
and -3, consecutively (Bender and Martinou, 2013).
Synchronously, inhibitor of apoptosis proteins (IAP) is
inhibited by Smac/DIABLO and HtrA2/Omi to promote
apoptosis. DNA fragmentation is a late event of apoptosis
that is induced by apoptosis inducing factor (AIF) and
endonuclease G (EndoG) released from the mitochondria
(Nirmala and Lopus, 2020). Both extrinsic and intrinsic
pathways are linked to each other via Bid, a pro-apoptotic
member of the Bcl-2 family (Igney and Krammer,
2002). Translocation of Bid to the mitochondria and
its cleavage into the truncated Bid (t-Bid) by caspase-8
permeabilizes the mitochondrial membrane, resulting in
the amplification of apoptotic signals (Billen et al., 2008).
The perforin/granzyme pathway, which is specialized
for infected cells, is executed by cytotoxic T-lymphocytes
and natural killer cells (Igney and Krammer, 2002;
Nirmala and Lopus, 2020). Immune cells in the infection
site release perforin to disrupt the membrane integrity of
the target cells. The resulting pores then induce apoptosis
with the action of granzyme A and B, a group of serine
proteases. Granzyme A causes DNA fragmentation in
a caspase-independent manner by cleaving the SET
complex, which inhibits NM23-H1, a tumor suppressor
gene (Elmore, 2007). Granzyme B activates procaspase-10
and contributes to the intrinsic pathway via caspase-9 and
-3.
2.2. Detection methods of apoptosis
Apoptotic features can be distinguished via various
methods based on cell morphology, DNA structure,
biochemical and electrochemical properties of apoptotic
cells either real-time or at an end point (Table 1). Recent
advances in the detection methods have facilitated data
acquisition with less intervention to the population of
interest, which mitigates the extent of a bias during data
processing.
2.3. Electron microscopy
Morphological features of apoptosis can be monitored
by electron microscopy, either by scanning (SEM) or
transmission electron microscopy (TEM). SEM provides
topographic data depicting cell surface alterations by using
a focused beam of high energy electrons (Burattini and
Falcieri, 2013). Nonhazardous electron bombardment on
the surface allows to obtain micrographs from a broader
perspective but in lower resolution when compared with
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Figure 1. Three pathways of apoptosis. The extrinsic signalling pathway is initiated through the binding of a ligand to transmembrane
receptors. The death domain plays a critical role in transmitting the death signal from the cell surface into the cell through caspase-8.
External stimuli such as cell stress, hypoxia, and radiation trigger the intrinsic pathway that causes cytochrome-c release from
mitochondria. Cytotoxic T-cells are the main controllers for the granzyme pathway, which results in caspase-10 activation. Granzyme
B can activate caspases in the targeted cell.

TEM, which is considered as the gold standard (Elmore,
2007). Instead of utilizing reflected electrons, the image
in TEM is obtained by the electron passage through the
specimen, which provides a higher resolution of inner
structures. On the other hand, the specimen preparation
is more laborious in TEM, and the field of view is much
smaller than SEM. Unfortunately, none of these methods
can be applied to real-time imaging as they serve as endpoint assays (Martinez et al., 2010). Acquisition of precise
data on the characteristic features of the early stages of
apoptosis is difficult to attain due to the dynamic nature
of apoptosis and stage-based variations among cell types
(Otsuki et al., 2003).
2.4. DNA fragmentation
As one of the hallmarks of apoptosis, DNA fragmentation
serves as a feasible tool for detection. DNA fragments
(approximately 200 bp) generated by endonuclease
cleavage during apoptosis can be visualized by agarose

gel electrophoresis (Banfalvi, 2017). This method is
favored due to its convenience. However, there are several
drawbacks associated with this approach that need to be
considered. For example, the sensitivity of the method
is directly proportional to the number of apoptotic cells,
requiring relatively a high number of apoptotic bodies
in the samples. Another disadvantage is the rate of false
positives that arises from the additional stress induced
during the sample preparation. Additionally, the inability
to detect the early stages of apoptosis constitutes yet
another disadvantage of this approach (Elmore, 2007;
Martinez et al., 2010).
End-labeling the resulting DNA fragments has led
to the development of other derivations such as In Situ
End Labeling (ISEL) and Terminal dUTP Nick EndLabeling (TUNEL). Both methods incorporate the labeled
nucleotides at the site of DNA strand break either by
DNA polymerase I in ISEL or terminal deoxynucleotidyl
transferase in TUNEL assay. Digitoxigenin-tagged or
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Table 1. Apoptosis detection methods.
Method

Platform

Scanning electron
microscopy (SEM)

- Electron microscopy

Transmission electron
microscopy (TEM)

- Electron microscopy

DNA fragmentation

- Agarose gel
electrophoresis

- Fluorescence
In situ end labeling (ISEL) microscopy
- Flow cytometry
- Fluorescence
Terminal dUTP Nick Endmicroscopy
Labeling (TUNEL)
- Flow cytometry
Comet assay

- Fluorescence
microscopy

Annexin V staining

Flow cytometry

Advantages

Disadvantages
- Lower resolution compared to TEM
- Provides information from a
- Requires expertise for using the instrument
larger area on the surface
- Inaccuracy due to variations of apoptotic
pattern among cell types
- Data is obtained from a smaller area than
SEM
- Specimen preparation is labor intensive
- Higher resolution than SEM
- Specimen exposed to harsh processing
- More detailed information of
conditions may destroy
the inner structure is obtained
- Requires expertise for using the instrument
- Inaccuracy due to variations of apoptotic
pattern among cell types
- Sensitivity is proportional to number of
apoptotic cells
- Convenient to perform
- False positivity due to additional stress
during sample preparation
- Inability to detect early phases of apoptosis
- Less sensitive than TUNEL due to labeling
only on 3’- ends
- N.A.
- False positive results due to DNA damage
other than apoptosis
- TdT can label both the 3’- and - Expensive due to enzyme and probes
5’-ends and blunt ends, more
- False positive results due to DNA damage
sensitive than ISEL
other than apoptosis
- Stage-dependent detection is
- Genotoxicity and cytotoxicity can lead to
possible
false positive results
- Sensitivity is higher than DNA
- Variability in case of manual scoring
fragmentation
- Detection in early apoptosis
- Should be assayed subsequent to staining,
- Direct quantification is
cannot be stored for later detection
possible by flow cytometry

- Fluorescence
microscopy
- Can be performed either by
Mitochondrial membrane
- Flow cytometry
live or fixed cells
potential measurement
- Confocal microscopy
- Fluorimetry
Hematoxylin-eosin and
Giemsa staining

- Light microscopy

Protein-based assays

- Western-blotting
- Fluorescence
microscopy

- Detects later events of apoptosis
- May underestimate the rate of apoptosis
- Cost-effective
therefore should be combined with another
method
- Time-consuming
- Difficulty in troubleshooting due to multi- Detection can be performed in
step nature
a mechanistic approach
- Requires additional procedures like fixation
or isolation

biotinylated nucleotides used in ISEL as well as dUTP
biotin nick end labeling in TUNEL can be monitored by
fluorescent microscopy and flow cytometry following
hybridization with appropriate probes (Ning et al., 2002;
Banfalvi, 2017). The difference between the two methods
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- Indirect method for assessing apoptosis
- Not applicable for all pathways

relies on the location of the label on DNA. In TUNEL assay,
TdT can label both the 3’- and 5’-ends as well as blunt
ends, whereas in ISEL assay, labeling is performed only
on the 3’-ends, which makes the former more sensitive
(Hall, 1999). As both methods are based on DNA strand
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break detection, the rate of false positives may be relatively
higher due to DNA damage rather than apoptosis.
2.5. Spectroscopy
The rate of apoptosis can be detected by monitoring the
absorption and emission of light by the sample. This
approach allows the use of different platforms ranging
from microscopes and spectrophotometers, with or
without fluorescent dyes, to flow cytometers based on laser
excitation. DNA-fragmentation-based methods, ISEL and
TUNEL, can be also categorized in this section due to
the use of fluorescent-tagged nucleotides. Comet assay is
another method for apoptosis detection, which is based on
the analysis of DNA strand breaks (Lorenzo et al., 2013).
This assay is also called single cell gel electrophoresis
due to the electrophoresis of cells embedded in agarose.
Following the lysis of cells with detergent and high salt,
electrophoresis is carried out at high pH value, resulting
in the formation of comet-like structures. The intact part
of DNA migrates relatively more slowly and is observed as
the head, whereas the damaged DNA migrates faster and,
thus, forms the tail of the comet. This method can sense
DNA stretching, nuclear budding, and apoptotic bodies
containing nuclear fragments, which are the indicators
of early apoptosis. The sensitivity of the method is
higher and the stage-dependent detection is more likely
than DNA fragmentation by agarose gel electrophoresis
(Choucroun et al., 2001).
Being one of the early indicators of apoptosis,
phosphatidylserine exposure serves as another useful
tool to detect apoptosis. Fadok et al. (1992) reported that
the macrophage phagocytosis during apoptosis in the
negative selection of thymocytes is attained through the
recognition of the exposed phosphatidylserine (Fadok et
al., 1992). Andree et al. (1990) subsequently showed that
the vascular anticoagulant α protein, thereafter, termed
as annexin V, binds to the phospholipid surface on the
cells in the presence of calcium ions (Andree et al., 1990).
This finding was exploited by Koopman et al. (1994) to
quantify the Annexin-V-positive, thus apoptotic, cells
by flow cytometry via using fluorescein isothiocyanate
(FITC)-labeled annexin V in the presence of a calcium
buffer (Koopman et al., 1994). Flow cytometry analysis
performed by fluorochrome-labeled annexin V, coupled
with 7AAD or PI possessing DNA binding capacity as an
indicator of late apoptosis, is now considered one of the
most common methods for quantification of apoptosis
(Zembruski et al., 2012).
Alterations in the mitochondrial membrane potential
followed by the cytochrome c release into the cytosol are
also considered an indication of early apoptosis (Martinez
et al., 2010). JC-1, rhodamine 123, and its derivatives
tetramethylrhodamine methyl (TMRM) and ethyl (TMRE)

ester are examples of the most frequently used fluorescent
lipophilic cationic probes for direct measurement of the
mitochondrial potential. This process can be monitored
by various methods such as flow cytometry, fluorescencedetecting microscopy, and fluorometry (Perry et al., 2011).
Rhodamine-based probes exhibit aggregation-caused
quenching (ACQ) characteristic (Li et al., 2020) as they
accumulate at high mitochondrial membrane potential
(MMP) conditions, forming aggregates and quenching
fluorescence. As the MMP decreases and depolarization
occurs, the fluorescent intensity increases until a complete
dissociation. Apart from the monochromatic rhodamine
derivatives, JC-1 acts as a dual-color probe, allowing
for the rational measurement based on aggregated and
monomer forms in red and green color, respectively (Perry
et al., 2011). As the name denotes, JC-1 forms reversible
J aggregates because of accumulation in mitochondria
in a healthy state, which emits red fluorescence. In the
case of apoptosis, the membrane permeability increases
followed by a reduction in the electrochemical potential,
resulting in a lesser uptake of JC-1, prevention of J
aggregate formation and emission of green fluorescence
(Sivandzade et al., 2019).
In addition to fluorescence detection, light microscopy
can also be exploited to distinguish apoptotic cells via
a histochemical staining procedure. Hematoxylin and
eosin as well as Giemsa stainings are employed to define
the morphological hallmarks of apoptosis such as dense
purple chromatin and darker cytoplasm containing round
bodies because of DNA fragmentation (Banfalvi, 2017).
2.6. Biochemical approaches
The protein components of apoptotic cascades,
activated through extrinsic or intrinsic pathways,
can be biochemically monitored by western blotting,
flow cytometry or immunocytochemistry based on
the availability of unlabeled or fluorochrome-labeled
antibodies. Some of the common members of the protein
network that are targeted for analysis include caspases,
Bcl-2 and p53 proteins as the main regulators, cytochrome
c as an indicator of the mitochondrial pathway and the
truncated form of bid, t-bid, as the hallmark of the crosstalk
between the intrinsic and extrinsic pathways (Ormerod,
2001). As these biochemical approaches require protein
isolation or cell fixation, they are considered as end-point
assays.
3. Noncoding RNAs
Historically, it was believed that the genetic information
stored in the genome is first transcribed into messenger
ribonucleic acids (mRNAs) followed by translation into
proteins. This concept was embraced for a long time as
proteins were considered as the structural and functional
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macromolecules in most, if not all, biochemical cellular
processes. In fact, H19, the first functional regulatory
ncRNA, was originally classified as a mRNA, which
was later shown to not code for a protein (Brannan et
al., 1990). Although some parts of this conventional
central dogma of molecular biology still hold true, recent
advances in transcriptome analyses make it imperative
to revise this dogma in that only 2% of the genome
codes for exons (Frith et al., 2005), requiring to account
for evolutionarily maintaining such a big chunk of the
genome without protein-coding capacity.
Genome
annotations in conjunction with the advances in RNA
sequencing technologies have uncovered that the majority
of the genome, without considering its coding capacity,
is transcribed into some types of RNA at least once
in one cell type under one condition throughout the
development (Birney et al., 2007). Actually, the genome
research in encyclopaedia of DNA elements (GENCODE)
consortium was initially established in 2003 to map
and identify primarily protein-coding genes by using
comparative genome analysis (Roest Crollius et al., 2000)
or gene discovery tools (Lander et al., 2001). To this extent,
the presence of open reading frames, polyadenylation
signals, splice sites, and promoter regions were used as
the landmarks to annotate protein-coding genes, which
naturally failed to annotate ncRNAs (Harrow et al.,
2006). This consortium then evolved to uncover all gene
variants following the realization that ncRNAs contribute
greatly to the transcriptome complexity. Consequently,
the consortium has identified seven major RNA
biotypes, namely immunoglobulin gene (IG), processed
transcripts, protein-coding transcripts, pseudogenes, read
throughs, to-be-experimentally-confirmed (TEC) and
T cell receptors (TR). Interestingly, the majority of these
transcripts encompass non-protein-coding transcripts. As
the number of and diversity in the eukaryotic proteome
fails to explain the organismal complexity, these nonprotein-coding transcripts may very well account for
some of the organismal complexity by diversifying the
eukaryotic gene regulatory mechanisms (Wilusz et al.,
2009).
ncRNAs are defined as biologically important yet nontranslatable transcripts that are generated through the
transcription of genomic loci (Costa, 2007). It is actually
quite challenging to categorize a novel transcript as a
coding or noncoding RNA especially if the transcript is
devoid of a long open reading frame (ORF). Perhaps, the
first criterion sought in a potential ncRNA is the absence of
an ORF longer than 100 amino acids (aa) (Frith et al., 2006;
Dinger et al., 2008). It is noteworthy to keep in mind that
some ncRNAs may possess long enough an ORF, resulting
in the incorrect annotation of genes. For example, the Xist
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transcript was initially classified as a mRNA due to the
presence of a 298-amino acid ORF (Borsani et al., 1991).
Thus, a second criterion, the existence of a high homology
in the ORF, was implemented to minimize errors (Dinger
et al., 2008). Unfortunately, some ncRNA transcripts
evolved from protein-coding genes and, thus, may possess
a high homology to protein-coding genes. Thus, it is
advised to look for experimental evidence such as in vitro
translatability or polysome association in distinguishing
between coding and noncoding transcripts (Galindo et
al., 2007). Rarely, the experimental evidence may not be
sufficient either as some genes code for both coding and
noncoding RNAs through alternative splicing (Lanz et al.,
1999; Kloc et al., 2005).
There appears to be a great heterogeneity in the size and
shape of ncRNAs. Costa (2007) used the size heterogeneity
to classify ncRNAs into 3 major subgroups: (1) long
ncRNAs (300-10,000 nt), (2) small ncRNAs (30-300 nt),
and (3) microRNAs (17-30 nt) (Costa, 2007). Based on
their structure, however, ncRNAs can be either linear
(Jorroux et al., 2017) or circular (Memczak et al., 2013).
There are two types of linear ncRNAs, (1) housekeeping
and (2) regulatory (Morey and Avner, 2004). Perhaps,
historically, the best-known examples of linear ncRNAs
are housekeeping ncRNAs such as transfer RNAs (tRNAs),
ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs)
and small nucleolar RNAs (snoRNAs). The recently
emerging regulatory ncRNAs can be classified into five
major subgroups, namely miRNAs, small interference
RNAs (siRNAs), piwi-interacting RNAs (piRNAs),
circRNAs, and lncRNAs (Yang et al., 2018). In this review,
we will cover miRNAs, circRNAs and lncRNAs.
3.1. Approaches for noncoding RNA detection and quantification
3.1.1. Microarray technology
Microarray technology was first employed by Patrick
Brown and his team to monitor the differential expression
of 45 Arabidopsis genes simultaneously via two-color
fluorescence hybridization in 1995 (Schena et al., 1995).
Potential applications of microarrays in gene expression
analysis broadened the scientific horizon by facilitating
high-throughput transcriptomics analyses. Prior to the
microarray technology, traditional techniques such as
northern blotting would be used to detect or quantify
individual RNA transcripts (Alwine et al., 1977).
Nowadays, microarray offers a hybridization-based,
quick and powerful alternative to examine differentially
expressed mRNAs and ncRNAs in the transcriptomes of
various cells and tissues (Thomson et al., 2007; Yang et al.,
2015; Li et al., 2019). Despite its convenience and relatively
low cost, the microarray technology requires careful
species- and transcript-specific probes to minimize false-
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positive signals. Also, it suffers from the resolution of data
being lower compared to sequencing-based approaches
(Table 2).
The typical workflow for a microarray experiment
begins with the isolation of RNAs from an experimental
sample (such as control and treated samples). Then,
reverse transcription is performed to convert the template
RNA into a more stable complementary DNA (cDNA)
while labeling each sample with one of the two distinct
fluorescent markers, for instance, Cy3 and Cy5. If the
amount of RNA sample is scarce to obtain enough signal,
the cDNA may be amplified, prior to fluorescent labeling,
to increase the template input. The dual-fluorescentlabeled cDNA pools are then mixed and loaded into a
microarray chip, which harbours thousands of probes
complementary to the genes of interest. A few methods
have been developed to improve the efficiency of labeling
as this step appears to be highly critical. Labeling involves
the use of fluorescent or biotin-labeled nucleotides that
are incorporated into cDNA or cRNA during synthesis.
Finally, washing, fixing, and scanning of the hybridized

arrays are performed to acquire the data (Sealfon and Chu,
2011; Bumgarner, 2013).
Although the protocols are highly optimized for the
analysis of mRNAs, there are additional optimization steps
that need to be considered while using microarray chips
for the analysis of ncRNAs. For example, microarraybased detection of miRNAs has challenges in labeling
probes and hybridization due to the shorter length and
lower abundance of miRNAs. Firstly, Locked Nucleic
Acid-modified (LNA) capture probes may be used to
eliminate acquisition problems of TM-normalised probe
sets (Castoldi et al., 2006). Furthermore, control probes
are helpful in improving sensitivity and accuracy during
hybridization and detection (Dong et al., 2013). Normally,
direct labeling is favored to eliminate PCR- and/or reverse
transcription-based artificial errors. Indirect labeling might
be advantageous, however, in the analysis of unstable and
rare miRNAs (Castoldi et al., 2006). Secondly, oligo d(T)based RT is not suitable for miRNA labeling since mature
miRNAs lack a poly(A) tail. Several direct and indirect
labeling methods were developed to circumvent this issue.

Table 2. Comparision of ncRNA analysis methods.
Method

Microarray

Next
Generation
Sequencing

Sensitivity and
Specificity

Advantages

- Cheaper than RNA-seq
- Less specific and - Easier data processing than
less sensitive than RNA-seq
- Fast high throughput
NGS and qPCR
profiling
- Detection of isoforms
- Profiling of organisms
- Very specific
without a reference genome
- Adjustable
- Broader dynamic range
sensitivity
than microarray, adjustable
sequencing depth

Quantitative - Sensitive
Real Time
- Medium
PCR
specificity

- Easy to perform
- Cheap

Northern
Blotting

- Ability to detect all forms of
a transcript (circRNA– linear
vs circular isoforms)
- RNase H based validation of
circularity (circRNA)
- Cheap
- Reverse transcriptase
independent

- Low sensitivity
- High specificity

Disadvantages

High–
Quantitativeness
throughput

- Cannot distinguish alternative
splicing events
Yes
- Low sensitivity for detecting
rare transcripts
- Massive data, difficult to store
- Bioinformatic expertise
required
Yes
- Non-standardized data
analysis tools affect biological
interpretation
- To quantify known ncRNAs
- Challenges in primer designs
- Artifacts due to genomic
rearrangement, trans splicing
Medium
and template switching
(circRNA)
- Amplification problems due to
short length of miRNA
- Time consuming
- Validate known ncRNAs
- Hazardous if performed with
radioactive isotopes
- High amount of starting
material

No

Quantitative

Quantitative

Quantitative

Semi-quantitative
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RT- and PCR-based artifacts can be eliminated by using
direct labeling. For instance, terminal deoxynucleotidyl
transferase (TdT) and poly(A) polymerase (PAP) can be
employed to add either an amine-modified or biotinconjugated tail into the terminal hydroxyl group (-OH)
of mature miRNAs to elevate sensitivity (Shingara et al.,
2005; Zhao et al., 2015). Notably, T4 RNA ligase might
be useful in labeling the 3’-end of miRNAs to avoid
inconsistencies in the labeling efficiency that might arise
from variations in the tail length (Wang et al., 2007).
On the other hand, indirect labeling methods have the
following advantages: 1) cDNA is more stable than RNA,
therefore, more resistant to subsequent manipulations,
and 2) scarce miRNAs can be labeled more efficiently (Li
and Ruan, 2009). One of the best established examples is
RT-based miRNA labeling through cDNA synthesis via
eight-nucleotide random primer labeled with two biotin
molecules (3′-(N)8-(A)12-biotin-(A)12-biotin-5′) (Liu et
al., 2008). Regardless of the labeling type, the short length
of miRNA may lead to cross-hybridization or background
signals during hybridization steps. Thus, proper measures
must be taken during chip production, with respect to the
number and sequence of probes, to minimize this problem
(Zhao et al., 2011; Leshkowitz et al., 2013).
Microarray-based profiling of lncRNAs and circRNAs
resemble that of mRNAs. However, RNA isolation of high
integrity from the control and test samples should be wellplanned. Regarding lncRNAs, rRNAs should be eliminated
as a priori step to enrich the lncRNAs. Then, each sample
should be amplified and transcribed into cRNAs without
any 3’-bias utilizing a random priming method (Yang et
al., 2015). The sample preparation for circRNAs differs
slightly as treatment with RNase R is required to enrich
for circRNAs prior to amplification and transcription into
fluorescent circRNA (Zhang et al., 2018). It should be
underlined that the random priming method is preferable
for both lncRNA and circRNA quantification (Yang et
al., 2015; Fan et al., 2019). Normally, microarray is an
efficient tool for circRNA quantification (Li et al., 2019).
However, the probes are typically designed specifically
complementary to the back-splicing junction of circRNAs.
Thus, it may be difficult to distinguish among the circRNA
isoforms stemming from the back-splicing of the same
mRNA.
3.1.2. RNA sequencing technology
Over the past decade, Next-Generation Sequencing
(NGS)-based transcriptome analyses have dominated the
field to search for novel noncoding transcripts that might
be the long-sought answer to the existence of a big chunk
of a genome without any protein-coding capacity. To this
extent, NGS is a widely used, indispensable and versatile
method to detect and quantify ncRNAs (Anamika et
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al., 2016; Arrigoni et al., 2016; Handzlik et al., 2020). In
addition to the use in expression profile analyses, novel
ncRNA isoforms can be discovered by NGS (Arrigoni et
al., 2016), attaining resolution at the nucleotide level. Thus,
the major advantage of NGS, compared to microarray, is
its sensitivity and resolution. Conversely, the requirement
for sophisticated equipment and non-standardized data
analysis tools are the main disadvantages of NGS-based
profiling (Whitley et al., 2016; Corchete et al., 2020).
RNA sequencing (RNA-seq) begins with the
preparation of an RNA sample of high integrity followed
by rRNA depletion or poly(A)-plus transcript selection,
cDNA synthesis, and library preparation (Zhao et al.,
2018). The sequencing libraries are typically prepared
from rRNA-depleted or poly(A)-plus-selected RNAs
(Zhao et al., 2018; Shi et al., 2021). The choice depends
on the biotype of RNA to be sequenced. For example,
mRNA-seq libraries are constructed from poly(A)plus-enriched transcripts as mRNAs carry a poly(A) tail
(Stark et al., 2019), except for histone mRNAs. However,
noncoding RNAs are not polyadenylated, making rRNA
depletion a more attractive choice (Potemkin et al.,
2021). In any case, rRNA depletion from total RNA is
necessary to avoid contamination of the libraries with
highly abundant ribosomal RNAs (Ding et al., 2018).
Furthermore, circRNA-seq requires an additional step,
RNase R treatment, to enrich the sample for circRNAs by
eliminating linear RNAs (Sekar et al., 2019). It should be
taken into consideration that the RNAse R treatment step
may lead to the loss of RNAse R-sensitive circRNAs (Szabo
and Salzman, 2016). In summary, a poly(A) selection
protocol is recommended if the main goal is to profile
protein-coding genes, whereas rRNA depletion is strongly
suggested for lncRNA and circRNA differential expression
analyses (Zhao et al., 2018).
Total RNA isolation followed by size-fractionation
is the preferable method for miRNA enrichment prior
to the library construction (Hafner et al., 2008). Reverse
transcription of small RNAs followed by amplification
and sequencing constitutes the basic workflow of miRNAsequencing. Ligation and polyadenylation steps are
performed to extend the short length of miRNAs, providing
binding sites for primers during amplification. Notably,
the error-prone nature of the miRNA-seq originates from
this extension step substantially (Benesova et al., 2021).
The choice of bioinformatics analysis methods is a
critical step in the analysis of RNA-seq data as it affects
biological interpretation directly (Table 2). miRNA-seq,
lncRNA-seq and circRNA-seq data analyses share the
following four common steps: (1) data pre-processing, raw
data quality control and adapter trimming (2) mapping
and annotation (3) differential expression analysis and (4)
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functional analysis (Fu and Dong, 2018; Babarinde et al.,
2019; Duan et al., 2019; Veneziano et al., 2015; GomesDuarte et al., 2021). Quality check of sequencing reads is
necessary to remove low-quality reads. It can be performed
via tools such as FastQC, FASTX-Toolkit, NGS QC Toolkit,
cutadapt, and PrinSeq. Numerous RNA pre-analysis tools
offer capabilities for both filtering and trimming RNAseq data such as the NGS-QC toolkit (Liu et al., 2019).
However, specific tools, like Qtrim, were developed for
quality trimming (Shrestha et al., 2014). In this step, clean
reads are obtained for circRNA and lncRNAs. Distinctly,
the miRNA reads are trimmed and cleaned by removing
the sequences smaller than 18nt or longer than 30nt (Han
et al., 2020). Additionally, calculation of Q20, Q30, GCcontent, and duplication level of the sequence is important
to assess the quality of reads before moving onto the
downstream steps, such as genome alignment (Peng et al.,
2018). Typically, de novo assembly is more suitable while
working with novel organisms, whereas the mapping
assembly approach is preferable in the presence of a
reference genome (Choudhuri, 2014). Lastly, differential
expression analyses between control and test groups can
be performed by DE analysis pipelines such as DESeq2 (Li
and Wang, 2021).
For many ncRNA researchers, it is a big dilemma to
select between RNA-seq and microarray as they are both
powerful and comprehensive approaches that facilitate
the genome-wide analysis of transcriptomes. The main
difference between microarray and RNA-seq is that the
former allows the profiling of known transcripts while the
latter can identify novel transcripts with a wide dynamic
range at a nucleotide resolution. The heightened resolution
of RNA-seq permits identification of various isoforms,
such as edited RNAs or template-independent extensions.
The experimental cost and the availability of a reference
genome are two other factors that affect the choice as well.
3.1.3. Quantitative polymerase chain reaction
qPCR is a traditional nucleic acid amplification method
that is widely used in ncRNA quantification (Zeka et
al., 2015; Lu et al., 2018; Panda, 2018). Basically, this
method relies on a direct relationship between the cycle
threshold (Ct) value and the logarithm of the starting
template amount (Karlen et al., 2007). The low cost makes
qPCR the preferable choice to quantify differentially
expressed ncRNAs compared to microarray and RNAseq approaches. However, this approach is not highthroughput and confined to validation of known and
selected candidates, without any possibility of novel
transcript discovery (Yaylak and Akgül, 2022).
The short length of and high sequence similarity
among miRNAs stand out as a major challenge in miRNA
quantification through qPCR. Therefore, a priori size

extension is employed to overcome this hurdle. The size
extension of miRNAs can be attained through the use
of two approaches, stem-loop RT (Chen et al., 2005) or
poly(A) tailing (Shi and Chiang, 2005). The polyadenylated
miRNAs can then be reverse transcribed simply by using
an oligod(T) primer to generate cDNA. Subsequently,
one universal and one miRNA-specific primer are used to
quantitatively measure miRNA amounts.
The physical composition of lncRNAs requires the use
of alternative approaches to synthesize cDNA. Random
primers should be opted to synthesize cDNAs from
circRNA and most lncRNAs, which lack a poly(A) tail
(Wilusz, 2016; Yaylak et al. 2019). Irrespective of cDNA
quality and quantity, qPCR has several disadvantages
for circRNA validation and quantification. For example,
divergent primers (Zhong et al., 2018) may amplify, instead
of circRNAs, genomic rearrangements, trans-splicing
events or cDNA generated due to template switching
during reverse transcription. Genomic DNA, without any
RNA, can be used as the template to examine the presence
of such rearrangements (Cocquet et al., 2006; Jeck and
Sharpless, 2014; Lasda and Parker, 2014). It should be
noted that certain amplicons might be surprisingly long
due to the presence of introns within some circRNAs. On
the other hand, RNAse R treatment is a useful strategy
to identify trans-splicing events typically generated from
linear RNAs (Yu et al., 2014). It is very unlikely that two
different RT enzymes will switch templates in the same
region. Thus, candidate circRNAs may be amplified from
two different reverse transcriptase-derived cDNAs to
eliminate potential template-switching-event-based backsplicing junction artifacts (Lasda and Parker, 2014; Yu et
al., 2014). Considering all these potential concerns, an RTbased characterization is not preferred in examining the
circularity of a novel circRNA.
3.1.4. Northern blotting
Northern blotting is a traditional but gold-standard
method that allows detection and quantification of
ncRNAs without any complex technical knowledge or
sophisticated equipment (Alwine et al., 1977). Northern
blotting is composed of three fundamental steps,
namely the size separation of RNAs through agarose gel
electrophoresis, transfer of the fractionated RNA onto
a nylon membrane and hybridization-based detection
and quantification (Yaylak and Akgül, 2022). Because
this method involves the separation of RNAs based on
their electrophoretic mobility, miRNAs of varying sizes
and different types such as pre- or mature miRNAs can
be simultaneously probed on the same filter (BofillDe Ros et al., 2019; Siddika and Heinemann, 2021).
Despite its simplicity and reliability, several drawbacks
are associated with northern blotting. For instance, it
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may be challenging to distinguish among miRNAs if
they share similar base composition and have the same
length, whereby cross-hybridization complicates the
analysis (Ouyang et al., 2019). Low sensitivity is another
major disadvantage of this method, requiring the use of
a high amount of RNA (He and Green, 2013). However,
alternative signal detection methods have been developed
to increase the specificity and sensitivity. Valoczi and his
colleagues introduced LNA probes to overcome both
the low sensitivity and labor problems of this technique
(Válóczi et al., 2004). Furthermore, Ramkissoon
developed 3’-digoxigenin-labeled RNA oligo probes as an
alternative to hazardous radioactive 32P-labeled probes
(Ramkissoon et al., 2006). Additionally, EDC [1-ethyl-3144 (3-dimethylaminopropyl) carbodiimide] together
with (DIG)-labeled LNA oligonucleotide probes not
only decreases exposure time nearly 1000-fold but also
increases sensitivity by generating clear signals with RNA
amounts as low as 5 fmol (Kim et al., 2010).
Detection of lncRNAs by northern blotting resembles
that of mRNAs. Perhaps the only point to consider is the
concentration of lncRNAs being much lower compared to
that of mRNAs. Analysis of circRNAs by northern blotting
is performed by standard northern blotting procedures,
but in combination with RNase R and RNase H treatments
(Schneider et al., 2018). It is suggested that northern
blotting should be preferred to validate circRNAs because
it is not affected by RT-related complications (Dodbele
et al., 2021). Additionally, northern blotting permits
quantification of both linear template and circRNAs
simultaneously.
3.2. microRNAs
miRNAs are an important group of endogenous singlestranded small ncRNAs of approximately 17-22 nt in
length that control gene expression post-transcriptionally
(Bartel, 2018). Most cognate miRNAs bind to the 3’
untranslated region (UTR) of target mRNAs although
there exist miRNA recognition elements (MRE) in other
parts of mRNAs as well. lin4 and let-7 constitute the first
examples of miRNAs, which were discovered during a
screen for genes that determine developmental timing
in C. elegans (Lee et al., 1993). Actually, these miRNAs
were identified as early as 1980 but remained as a mystery
due to their non-protein-coding capacity (Horvitz and
Sulston, 1980). The early 2000s witnessed the discovery
of a number of miRNAs in C. elegans and Drosophila
(Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and
Ambros, 2001), paving the way for searching for cloningand sequencing-based identification of miRNAs in many
other species (Pasquinelli et al., 2000; Davis-Dusenbery
and Hata, 2010; Friedländer et al., 2014). Although it was
difficult to distinguish between siRNAs and miRNAs at
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first, illumination of the biochemical basis of RNAi-based
gene silencing led to the recognition of miRNAs as a new
group of small ncRNAs (Mello and Conte, 2004). Doubts
about the functionality of these small molecules dissipated
following the observation that mutations in Dicer and
AGO proteins are either fatal in animals or cause several
developmental defects in animals and plants (Knight
and Bass, 2001). Subsequent studies demonstrated that
miRNAs play an essential role not only in development
but also in key cellular processes such as metabolism, stem
cell differentiation, cell death or cell cycle (Lynam-Lennon
et al., 2009; Xiao and Rajewsky, 2009; Bartel, 2018).
3.2.1. Biogenesis of microRNAs
miRNAs are produced predominantly by the canonical
miRNA pathway, which is initiated by the synthesis of
a primary miRNA (pri-miRNA) by RNA polymerase II
(Figure 2A; Lee et al., 2002). The first processing event is
carried out in the nucleus by a microprocessor complex
made up of an RNA-binding protein DiGeorge Syndrome
Critical Region 8 (DGCR8) and an endonuclease III
enzyme, Drosha (Denli et al., 2004). The microprocessormediated processing in the nucleus converts the primiRNA into a 60-70-nt precursor miRNA (pre-miRNA),
which is characterized by a 2-nt protruding extension
in its 3’-end and a 5’-phosphate group (Lee et al., 2002).
Drosha cooperates with DCRC8 in human and Pasha in
Drosophila to perform the nuclear processing event (Denli
et al., 2004; Han et al., 2004). The resulting pre-miRNAs
are transported into the cytoplasm by Exportin-5, a Ran
GTPase (Yi et al., 2003). The cytoplasmically-localized
pre-miRNAs that possess a loop in the middle are
subjected to a second round of processing by Dicer, yet
another endonuclease III group of enzymes (Hutvágner
et al., 2001). Dicer is accompanied with TRBP in human
to generate a duplex with partial complementarity
(Chendrimada et al., 2005). The polarity of the miRNA
strand dictates the name of the mature miRNA. The
miRNA processed from the 5’-end of the pre-miRNA
hairpin is called the 5p strand, while the 3p strand
stems from the 3’-end of the hairpin. Interestingly, both
strands can be potentially loaded into an RNA-induced
silencing complex (RISC) depending on the cell type or
cellular states (Yoda et al., 2009). The strand selection at
this point appears to be governed by the thermodynamic
stability at the 5’-end of the miRNA duplex. The strand
that is thermodynamically less stable at its 5’-end,
called the guide strand, is loaded, in an ATP-dependent
manner, into the RISC complex composed at least of
argonaute (AGO) and a glycine and tryptophan-rich 182
protein (GW182) (Siomi and Siomi, 2009). The resulting
microRNA-induced silencing complex (miRISC) typically
binds to the 3’UTR of the target mRNA through impartial
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complementarity and represses gene expression either by
inducing mRNA degradation or translational repression.
In contrast to animals, plant miRNAs possess 2-O methyl
groups at their 3’-ends (Yu et al., 2005). The cellular
fate of the other strand of the miRNA duplex, called the
passenger strand, is primarily determined by its degree
of complementarity with the guide strand. For example,
passenger strands without any central mismatches with
the guide strands are cleaved by AGO2 (Ha and Kim,
2014).
The noncanonical miRNA biogenesis pathway
involves production of pri-miRNAs that do not go
through Drosha- or Dicer-mediated cleavage. Perhaps the
best-known example of such miRNAs are mirtrons, those
that are generated from debranched introns that enter the
biogenesis process as pre-miRNAs (Ruby et al., 2007). A
subset of mirtrons may possess a 5’- or 3’ tail at the premiRNA hairpin, which is processed further by a nonDrosha nuclease prior to entrance into the downstream
pathway (Babiarz et al., 2008). Other than mirtrons, a
second group of noncanonical miRNAs are generated
from endogenous short-hairpin RNAs (shRNAs) (Babiarz
et al., 2008). Endogenous versions of these shRNAs are
transcribed by RNA pol II, which also determines the 5’
start site. As the 5’-end of the transcript is capped, this
pathway of miRNA biogenesis yields only the 3p strand
(Xie et al., 2013). Subsequent studies have shown that
hairpins at the 5’ regions of certain mRNAs may serve
as the Dicer substrate to produce miRNAs in a Droshaindependent pathway (Zamudio et al., 2014). A third type
of non-canonical miRNAs are processed from chimeric
transcripts that contain another gene in addition to the
miRNA gene. In this case, an initial processing is required
to release the hairpin that can serve as the Dicer substrate
(Ender et al., 2008).
The miRNA processing machinery appears to be
highly consistent in maintaining homogeneity at miRNA
ends, accomplishing nearly 98% homogeneity in the
strand selection and terminal identities (Chiang et al.,
2010). However, the increase in the depth of small RNAseq coverage revealed the existence of multiple miRNA
isoforms called isomiRs that encompass heterogeneity
either at a single or both ends or the final miRNA body.
Such variations may have a fundamental effect on target
repertoire as the isoforms end up harboring a different
seed sequence especially due to the heterogeneity at
the 5’ end (Bartel 2018). These isomiRs are generated
through either template-dependent or –independent
variations (Dhanoa et al., 2019). Template-dependent
variations include trimming events carried out by
exonucleases whereas template-independent posttranscriptional variations involve either RNA editing or

3’-tailing events. Most isomiRs are actually generated
from miRNA duplexes, the cytoplasmic Dicer cleavage
products (Dhanoa et al., 2019). Variations at the 3’-ends
are produced through terminal-nucleotide-transferase
or 3’-exonuclease activities (Kim et al., 2016). Such
variations do not influence the target selection as they
do not change the seed sequence. However, 3’-isomiRs
are reported to modulate miRNA processing or stability
(Ha and Kim, 2014). The production of edited miRNAs
involves adenosine deaminases (ADAR, adenosine
deaminases acting on RNA), which was first reported for
pre-miR-22 through conventional sequencing (Luciano et
al., 2004). Subsequent next-generation-sequencing (NGS)
studies reported a plethora of edited miRNAs (Hoon et
al., 2010). Currently, there is a free online database called
IsomiR Bank (http://mcg.ustc.edu.cn/bsc/isomir/) that
houses annotated isomiRs (Zhang et al., 2016).
The subcellular compartmentalization of canonical
miRNAs or isomiRs is primarily determined by
the composition of miRISC complexes (Figure 2B).
Cytoplasmically, miRISCs can localize at different
nonmembranous foci, endomembrane structures, or
mitochondria (Akgül and Erdoğan, 2018; O’Brien et al.,
2018). The nonmembranous compartments that were
reported to serve as the cytoplasmic site of miRNA action
include processing bodies (P bodies) (Pillai et al., 2005),
stress granules (SGs) (Leung et al., 2006), polysomes
(Olsen and Ambros, 1999), germ granules (Wu et al., 2017)
and neuronal granules (Zalfa et al., 2006). Interestingly,
the switches from one cytoplasmic site to another were
reported for various miRNAs, and this switch appears to
be governed by the constituents of the miRISC complex
modulated by extracellular signals (Molotski and Soen,
2012; Wu et al., 2013; Göktaş et al., 2017; Cosacak et al.,
2018). miRISCs may also function in several organelles
such as the trans-Golgi network and endosomes (Bose
et al., 2017), rough endoplasmic reticulum (rER) (Wu et
al., 2013), multivesicular bodies (MVBs) (Gibbings et al.,
2009), lysosomes (Gibbings et al., 2009), mitochondria
(Kren et al., 2009) and nucleus (Gagnon et al., 2014).
Additionally, numerous studies report the existence of
extracellular miRNAs in biological fluids either in the
form of enclosed exosomes, microvesicles and apoptotic
bodies or as miRNP complexes without enclosure (Cortez
et al., 2011; Turchinovich et al., 2011; O’Brien et al., 2018).
3.2.2. Mode of action of miRNAs
Most miRNAs bind to the 3’ UTR of their target mRNAs
but there are several studies that report the existence of
miRNA response elements (MREs) on the other parts of
target RNAs such as 5’-UTR, coding region or promoter
regions (Bartel, 2018). Target recognition typically
involves Watson-Crick pairing between the MRE and the
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miRNA seed region encompassing the nucleotides 2-7
(Bartel, 2009). The extent of pairing between the MRE
and the miRNA dictates the repression mode. In the
presence of extensive complementarity, the target mRNA
destabilization is initiated through an endonucleolytic
cleavage if the AGO protein has the slicing activity
(Meister et al., 2004). The AGO-mediated endonucleolytic
cleavage, which is the dominating mode of action in
plants (Jones-Rhoades et al., 2006), has been reported
only for a few mammalian transcripts (Yekta et al., 2004).
In human and other mammals, a partial complementarity
between the MRE and the miRNA leads to deadenylationdependent mRNA destabilization (Figure 2C; (Jonas and
Izaurralde, 2015). In this case, the AGO protein without
an endonucleolytic cleavage activity recruits the TNRC6
protein, which subsequently interacts with poly(A)binding protein (PABP) and deadenylase complexes
such as the PAN2-PAN3 complex and the CCR4-NOT
complex (Jonas and Izaurralde 2015). The TNRC6 protein
appears to have a dual function as it also modulates the
translational efficiency of the target mRNA by interacting
with the CCR4-NOT complex and the DDX6 helicase
(Chu and Rana, 2006). An interaction between DDX6 and
eIF4E transporter then leads to translational repression by
acting as a competitor for the eIF4G-eIF4E interaction,
which plays an essential role in enhanced translation
(Kamenska et al., 2016).
In the late 2000s, there was a dispute over whether
miRNA-mediated gene regulation is primarily governed
by target mRNA destabilization or translational
repression in mammals (Filipowicz et al., 2008; Guo et
al., 2010). Subsequent studies revealed that although
translational repression also contributes to the TNRC6mediated gene regulatory activity in animals, the ensuing
target mRNA destabilization takes over the regulation as
the predominant mode of regulation in post-embryonic
cells (Eichhorn et al., 2014; Guo et al., 2014; Bartel,
2018). Excluding the effect of mRNA destabilization,
translational repression appears to account for 6%–26% of
the endogenous target repression in mammals (Eichhorn
et al., 2014). Initially, conflicting results were reported
with respect to the miRNA-mediated translational
regulation taking place at the initiation or post-initiation
stage (Nilsen, 2007; Filipowicz et al., 2008; Carthew
and Sontheimer, 2009). However, a consensus has later
emerged on the notion that miRNAs regulate capdependent translation initiation that involves ribosome
scanning and eIF4A (Jonas and Izaurralde, 2015). In the
embryonic cells, on the other hand, the sole repressive
mode is the translational regulation as the tail shortening
modulates the translational efficiency of mRNAs rather
than their stability (Subtelny et al., 2014). In fact, the
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zebrafish embryo studies supported this notion of TNRC6mediated translational suppression in the embryonic cells
(Bazzini et al., 2012). Congruently, a considerable fraction
of miRNAs was reported to associate with polysomal
fractions in 1h Drosophila embryos, some of which switch
to non-polysomal fractions upon the maternal-to-zygotic
transition (Cosacak et al., 2018).
The miRNA-mediated gene regulation is not limited
to target destabilization or translational repression.
Interestingly, there are reports on miRNA-mediated
translational activation especially under non-physiological
conditions. For example, Fragile-X-mental retardation
related protein 1 (FXR1) and AGO2 independently
associate with mRNAs that possess AU-rich elements
(AREs) in their 3’-UTRs and activate translation upon
serum starvation (Vasudevan and Steitz, 2007). A similar
phenomenon was reported in quiescent cells, further
confirming the existence of this mode of repression under
specific cellular conditions (Truesdell et al., 2012; Bukhari
et al., 2016). In the nucleus, miRISCs can mediate target
destabilization similar to their cytosolic effect (Nishi et al.,
2013). Amazingly, miRISCs can suppress transcription,
alter chromatin dynamics or modulate alternative splicing,
suggesting a transcription or splicing factor-like function
of miRNAs (Alló et al., 2014; Bottini et al., 2017; M et al.,
2017; Miao et al., 2019).
It is important to note that miRNAs as micromanagers
of post-transcriptional regulation are subject to intense
genetic and epigenetic regulation as well. We refer the
readers to other reviews on this topic due to space
limitation (Hamid and Akgül, 2014; Gebert and MacRae,
2018; Alkan and Akgül, 2022). Additionally, recent studies
suggest an intricate interplay among different types of
RNAs such as mRNAs, miRNAs, and circRNAs (Rong et
al., 2017; Patop et al., 2019).
3.2.3. miRNAs in apoptosis
The first example of a miRNA that regulates apoptosis,
bantam, was reported in Drosophila 18 years ago
(Brennecke et al., 2003). bantam was identified during
a screen for genes that modulate tissue development in
Drosophila (Hipfner et al., 2002). It was later shown to
target the proapoptotic gene hid and to suppress apoptosis
during development. The same year, miR-14 emerged as
the second miRNA in the fly that suppresses cell death by
targeting DrICE, the Drosophila homologue of caspase-3
(Xu et al., 2003). The use of a library of miRNA inhibitors
facilitated the functional identification of numerous
pro- and antiapoptotic miRNAs in HeLa and A549 cells,
clearly indicating that miRNA-mediated regulation of
apoptosis is not limited to Drosophila (Chen et al., 2005).
The ensuing years experienced an explosion of reports
on miRNA-mediated regulation of apoptosis in different
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Figure 2. microRNA biogenesis and mode of actions. (A) Canonical and non-canonical pathways of microRNA biogenesis. In the
canonical pathway, hairpin structured pri-microRNAs are converted into ~70–80 nucleotide precursor microRNAs (pre-microRNAs)
by the RNase III enzyme Drosha in the nucleus. Pre-microRNAs are exported from the nucleus to the cytoplasm by Exportin-5. Dicerprocessed mature microRNAs are incorporated into a microribonucleoprotein complex (miRISC complex). Non-canonical miRNA
biogenesis does not involve Drosha. (B) Localization of miRISCs. miRISCs can be localized in (1) rough endoplasmic reticulum, (2)
Golgi, (3) mitochondria, (4) vesicles, (5) free polysomes, and (6) cytoskeleton-bound polysomes. (C) Possible mechanisms for miRNAmediated gene regulation. Binding of a miRNA to its target mRNA triggers either mRNA decay/cleavage or inhibition of translation.
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cellular contexts (For reviews, see (Lynam-Lennon et al.,
2009; Subramanian and Steer, 2010; Chen et al., 2014; Su
et al., 2015).
Bioinformatics analyses suggest that over 60% of
human protein-coding genes are under selective pressure
to maintain interaction with miRNAs (Friedman et al.,
2009). Considering the fact that each mRNA may have
multiple MREs (Chou et al., 2018) it is plausible to suggest
that thousands of mRNAs may be targeted by miRNAs
as part of regulation of apoptosis. In fact, there are over
fifty well-documented miRNAs targeting a repertoire
of pro- and antiapoptotic mRNAs involved in intrinsic
or extrinsic apoptotic pathways (Figure 1 and Table
3). Strikingly, most critical regulators of apoptosis are
targeted by miRNAs. To highlight a few of these miRNAs
that modulate the extrinsic pathway, miR-21 was reported
to regulate the FasL/Fas apoptotic pathway by directly
targeting FasL in HEK293 and the pancreatic cancer
PANC-1 cell line (Wang et al., 2013). The Fas receptor, on
the other hand, is targeted by miR-20 in the osteosarcoma
SAOS-2 cell line (Huang et al., 2012). In the intrinsic
pathway, miR-204 promotes apoptosis by downregulating
the expression of Bcl-2 in N87 and GTL-16 gastric cell
lines in addition to HEK293T cells (Sacconi et al., 2012).
The proapoptotic Bax protein is a key regulator of the
intrinsic apoptotic pathway, which is regulated by miR365 in the pancreatic cancer cell lines PANC-1 and AsPC1 (Hamada et al., 2014). miR-27a/b modulates apoptosis
by downregulating Apaf-1 in HEK293 cells and primary
cortical neurons (Chen et al., 2014). Both pro- and active
caspases may be targeted for regulation by miRNAs. The
rate of apoptosis is attenuated in human nucleus pulposus
cells by miR-155, which inhibits caspase-3 expression
(Wang et al., 2011). miR-874-mediated downregulation
of caspase-8 results in the induction of necrosis in
cardiomyocytes (Wang et al., 2013) while miR-874
induces apoptosis in the breast cancer cell lines MCF7 and
MDA-MB-231 by modulating the expression of CDK9.
This suggests that the phenotypic outcome of a miRNA
varies with the cellular contexts. miR-24a modulates eye
morphogenesis by negatively regulating the expression of
caspase-9 (Walker and Harland, 2009). There are many
other regulatory genes such as STAT3, FoxO1, Akt, p53
and PI3K that are targeted by pro- or anti-apoptotic
miRNAs (Figure 1 and Table 3).
3.3. Circular RNAs
3.3.1. Characteristics of circular RNAs
circRNAs are covalently closed and functional RNA
transcripts that possess neither a poly(A) tail nor a 5’cap (Meng et al., 2017). circRNAs were first reported
in viroids as early as 1976 (Sanger et al., 1976). Three
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years later, circRNAs were identified in the cytoplasm
of eukaryotic cells by electron microscopy (Hsu and
Coca-Prados, 1979). The unique RNA transcript of the
DCC gene was discovered to contain two exons joined
accurately at splice sites but in an inverse order relative to
their genomic context. Nigro and his colleagues referred
to these molecules as “scrambled exons” to describe such
an abnormal RNA molecule resulting from canonical
splicing (Nigro et al., 1991). These scrambled transcripts
were not abundant, expressed at approximately 1/1,000th
the level of the canonical DCC transcript, and mainly
located in the cytoplasm. The science community
disregarded these transcripts assuming that they are the
products of erroneous splicing (Jeck et al., 2013). In the
1990s, the circ Sex-determining region Y (Sry) was shown
to be a functional circRNA in mouse testis (Capel et al.,
1993). Similarly, circMLL was observed to derive from
scrambled exons (Caldas et al., 1998).
The 2010s witnessed the discovery of several circRNAs
in parallel to the development of high-throughput RNA
sequencing methods and appropriate bioinformatics
pipelines. In 2012, Salzman and his team provided
convincing evidence that circRNAs are abundant
RNA isoforms in human cells (Salzman et al., 2012).
Subsequently, circRNAs were shown to be evolutionary
conserved across species and expressed in most organisms,
such as most metazoans, archaea, yeast, and plants (Patop
et al., 2019). The abundance of circRNAs is specific to cell
type (Ruan et al., 2019). The circular structure of circRNAs
confers resistance to exonuclease-mediated degradation
by RNAse R, making them ideal biomarker candidates
due to their increased stability (Ren et al., 2020).
3.3.2. circRNA biogenesis and decay
Mutational analyses on circRNA expression vectors
and the use of a splicing inhibitor, isoginkgetin, showed
that the canonical splicing machinery is necessary and
adequate for circRNA biogenesis. However, circRNAs
are produced through back-splicing, which is generally
coupled with canonical-splicing. There is no additional
motif required for circularization other than the
canonical 5’- and 3’-splice sites (Starke et al., 2015).
There appears to be a global competition between backsplicing and canonical splicing in the circRNA-producing
loci. The main difference between the back-splicing and
the canonical splicing is that the back-splicing joins
the downstream 5’-splice donor site into the upstream
3’-splice acceptor site (Lasda and Parker, 2014). This
reaction is sterically highly unfavorable (Chen et al., 2020).
Therefore, back-splicing is less efficient than canonical
splicing; however, cis- and trans-acting elements facilitate
these sterically unfavorable reactions and regulate the
competition between the back-splicing and the canonical
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Table 3. MicroRNAs in apoptosis.
Disease

miRNA

Tissue/Cell line

Regulation

References

Acute kidney injury

let-7/miR-98
family

Targeted
member

HUVECs

Up

Caspase-3

(Li et al., 2015)

hsa-miR-34a

HL-60 and THP-1 cells

Down

HMGB1

(Liu et al., 2017)

Up

FAS

(Francis et al., 2014;
Wang et al., 2013)

Up

PTEN, FOXF2,
(Shi et al., 2011)
and

Down

mTOR

(Hu et al., 2014)

Down

Jak2

(Wang et al., 2014)

Acute Myeloid
Leukemia Cells
Alcoholic liver
disease
Breast cancer

hsa-miR-301

Breast cancer

hsa-miR-99a

Breast cancer

hsa-miR-101

Breast cancer

hsa-miR-142-3p

Breast cancer
Breast cancer and
normal tissues
Cardiomyocytes

hsa-miR-192

Hepatic stellate cells,
PANC-1 cells
MCF-7, MDA-MB-231,
MDA-MB-468, and T47D
SK-BR-3,MDA-MB-435s,
MCF-7 and MDA-MB-231 cells
MCF-7, MDA-MB-231 cells
Breast cancer and normal breast
tissues
Hs578Bst, MDA‑MB‑231, MCF‑7

hsa-miR-874

MCF7 and MDA-MB-23

hsa-miR-874

Cardiomyocytes

Down

Caspase-8

(Wang et al., 2013)

Cervical cancer

hsa-miR-744

HeLa, C-4-1, Ca Ski, SiHa

Up

BCL 2

(Chen and Liu 2016)

Cervical cancer
Cervical cancer,
Prostate cancer
Cholangiocarcinoma
Chronic lymphocytic
leukemia
Chronic lymphocytic
leukemia

hsa-miR-143

HeLa cells

Up

HIF-1α

(Zhao et al., 2017)

hsa-miR-133b

HeLa cells, PC-3 cells

Up

FAIM

(Coccia et al., 2020)

hsa-miR-29

KMCH cells

Down

Mcl-1

(Mott et al., 2007)

hsa-miR-15a

Peripheral blood

Down

BCL2

(Cimmino et al., 2005)

hsa-miR-16-1

Peripheral blood

Down

BCL2

(Cimmino et al., 2005)

Colorectal cancer

hsa-miR-30b

W480, DLD1, HCT116, HCT15,
KM12 and Ls174t cells

Down

Colorectal cancer
Epithelial ovarian
cancer
Esophageal squamous
cell carcinoma
Gastric cancer

hsa-miR-148a

RKO, SW480 and Lovo

hsa-miR-124

Gastric cancer

hsa-miR-421

Gastric cancer

hsa-miR-106a

Gastric cancer

hsa-miR-204

Gastric cancer

hsa-miR-136

Gastric cancer

hsa-miR-185

MGC803

Up

Gastric cancer

hsa-miR-200c

Down

Gastric cancer

hsa-miR-100

BGC‑823
MGC-803, HGC-27 and
MKN-45 cells

Bcl‑2, survivin
(Fan et al., 2018)
and XIAP
EDNRA
(Wei et al., 2018)

Up

RNF144B

hsa-miR-21

Up

Bach-1

(Mansoori et al., 2019)

Down

Caveolin 1

(Chen et al., 2019)

Up

CDK9

(Wang et al., 2013)

Down

KRAS,
PIK3CD and
BCL2
Bcl-2

(Zhang et al., 2011)

SKOV3 and OCVAR3 cells

Down

PDCD6

(Yuan et al., 2017)

hsa-miR-141

KYSE cell lines

Up

YAP1

(Imanaka et al., 2011)

hsa-miR-18a

MGC-803, HGC-27
MGC-803, HGC-27, BGC-823,
SGC-7901
Stomach

Down

HIF 1 ALPHA (Wu et al., 2015)

Up

CASPASE 3

(Wu et al., 2014)

Up

FAS

(Wang et al., 2013)

Down

BCL2

(Sacconi et al., 2012)

Up

AEG-1, BCL2

(Yu et al., 2018)

N87, GTL-17, HEK293T
MGC-802, BGC-823,
SGC-7901, AGS, SNU-1,
SNU-16, and RF-1
and GES-1 cell lines

(Liao et al., 2014)

(Yang et al., 2016)
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Table 3. Continued.
Disease

miRNA

Glioma

hsa-miR-125a-3p

Hepatocellular
carcinoma (HCC)
Human Embryonic
Kidney cells, primary
cortical neurons
Human nucleus
pulposus cells
Influenza virus A
infection
Laryngeal cancer
Laryngeal squamous
cell carcinoma
Lung cancer
Myocardial ischemia
reperfusion
Nasopharyngeal
carcinoma (NPC)
Non-Hodgkin
lymphoma
Non-small cell lung
cancer
Non-small cell lung
cancer
Non-small cell lung
cancer
Non-small cell lung
cancer

hsa-miR-193a

Tissue/Cell line
Normal human brain tissues,
Glioma patient cells
HCC tumor tissues and adjacent
normal tissues

Regulation

Targeted
member

References

Down

Nrg1

(Yin et al., 2015)

Up

BMF

(Wang and Wang, 2018)

hsa-miR-27a/b

HEK293, primary cortical
neurons

Down

Apaf-1

(Chen et al., 2014)

hsa-miR-155

Human nucleus pulposus cells

Down

Caspase-3

(Wang et al., 2011)

Down

COX6C

hsa-miR-34c

Primary human bronchial
epithelial cells
M4e cells

Down

BCL2

(Othumpangat et al.,
2014)
(Li et al., 2018)

hsa-miR-221

HEp-2

Up

APAF 1

(Sun et al., 2015)

hsa-miR-203

Lung cancer tissues

Up

SRC

(Wang et al., 2014)

hsa-miR-15b

Adult Sprague–Dawley (SD) rats

Up

Bcl-2

(Liu et al., 2013)

hsa-miR-125b

NPC tissues

Up

A20/NF-κB
signaling
pathway

(Zheng et al., 2017)

hsa-miR-181a

SU-DHL-4, SU-DHL-10

Up

BIM

(Lwin et al., 2010)

hsa-miR-3666

A-549

SIRT7

(Shi et al., 2016)

hsa-miR-7

Lung

Down

SMARCD1

(Hong et al., 2016)

hsa-miR-25

A549 and 95-D cells cells

Up

MOAP1

(Wu et al., 2015)

hsa-miR-34b

A549 and SPC-A-1 cells

Down

Met, p53,
Mmp2

(Wang et al., 2013)

Up

Bax

(Miao et al., 2019)

Up

Bcl2

(Zhang et al., 2017)

hsa-miR-4276

Osteoarthritis

hsa-miR-29a

Osteoblastoma

hsa-miR-146a

Human articular cartilage
samples
MC3T3-E1 cells

Osteosarcoma

hsa-miR-20

SAOS-2

Down

Fas

(Huang et al., 2012)

Pancreatic cancer

hsa-miR-365

PANC-1 and AsPC-1

Down

Bax

(Hamada et al., 2014)

Prostate cancer
Transitional cell
carcinoma

hsa-miR-130a

PC-3
T24 TCC cell line and bladder
TCC samples

Down

SLAIN1

(Fujita et al., 2015)

Up

FOXO1

Guo et al., 2021

hsa-miR-96

splicing (Chen and Yang, 2015). Despite the inefficiency
of back-splicing, circular isoforms of hundreds of human
transcripts accumulate proportional to their parental
linear transcripts, probably due to their covalently-closed
structure that insulate circRNAs from exonucleasemediated degradation (Barrett and Salzman, 2016; Ma et
al., 2020).
Two biogenesis models have been proposed to
describe the underlying mechanism of the back-splicing
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reaction, namely lariat-driven circularization and intronpairing circularization (Figure 3A). Broadly speaking,
the fundamental difference between the two models is
the order of the two modes of splicing (Chen and Yang,
2015). The subsequent back-splicing of lariats produced
from exon-skipping to restore the exon content within a
gene during canonical splicing produces a circRNA in the
lariat-driven circularization model (Jeck et al., 2013; Yang
et al., 2017). On the other hand, to overcome the natural
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disadvantage of the unfavorable back-splicing ligation,
the inverted repeats in flanking introns bring the acceptor
and donor sites into a close proximity by creating base
pairing (Jeck et al., 2013; Liang and Wilusz, 2014). In some
cases, specific motifs on flanking introns are occupied by
RNA-binding proteins such as QKI to ease circularization
(Conn et al., 2015). Surprisingly, it was documented that
ds-RNA-specific adenosine deaminase (ADAR) enzymes
(Ivanov et al., 2015) and ATP-dependent helicase A
(DHX9) (Kristensen et al., 2018) repress the biogenesis
of circRNAs by base pairing with the flanking inverted
repeats. Additionally, the back-splicing may also generate
isoforms from the same locus. Alternative splice site
selection results in alternative back-splicing events, which
generates isoforms that contain cassette exons, alternative
5’- and 3’-splice sites and introns (Li et al., 2020).
Although circRNA biogenesis is partially characterized,
our current understanding of circRNA decay is highly
limited. In contrast to mRNAs with poly(A) tails,
circRNAs should be degraded by an endoribonucleolytic
attack owing to their ring structure (Guo et al., 2020).
circRNA degradation comes about through either
a primary sequence-dependent- or a 3D-structuredependent manner (Hansen et al., 2011; Guo et al., 2020).
For example, circRNA Cdr1as is degraded by AGO2
protein with the assistance of miR-671 (Hansen et al.,
2011). Although the parental linear mRNA and circRNA
share identical primary sequences, it is unknown as to
how cells distinguish between circular and linear isoforms
for degradation. One potential explanation could be the
unique 3D structure of circRNAs that might be recognized
by RBPs to distinguish circRNA specifically.
3.3.3. Functions of circRNAs
Despite the concerns over the functionality of circRNAs,
increasing evidence suggests that circRNAs modulate
gene expression in a cell-specific manner (Figure 3B).
The biological functions of circRNAs are grouped under
three mechanisms: (1) transcriptional regulation of
parental linear mRNAs by exonic-intronic circRNAs,
(2) miRNA sponging, and (3) gene regulation through
circRNA:protein interactions (Wilusz 2018; Huang et
al., 2020). Although most circRNAs are localized in the
cytoplasm (Li et al., 2019), a fraction of circRNAs exist in
the nucleus. circRNAs generated from exons and retained
introns are classified as exon-intron circRNAs, which
promote transcription of their parental genes through
U1snRNP interaction (Li et al., 2015). Additionally,
circular intronic RNAs (ciRNAs) can accumulate in the
nucleus and induce the expression of a parental gene
by regulating RNA polymerase II activity (Yang et al.,
2018). Surprisingly, Xu and Zhang claim, based on the
analysis of RNA-seq data from multiple tissues of humans,

macaques and mice, that most mammalian circRNAs are
not functional as they probably originate from splicing
errors (Xu and Zhang, 2021).
Numerous studies report that circRNAs may
sequester miRNAs by acting as competing endogenous
RNAs or miRNA sponges (Panda, 2018). Considering
the importance of miRNAs in post-transcriptional gene
regulation, such circRNA:miRNA interactions may have
a fundamental effect on the abundance of miRNA targets.
Due to the low abundance of circRNAs, it was assumed
in the mid-2010s that circRNAs should contain multiple
miRNA binding sites to act as a miRNA sponge. Based
on this assumption, the sponging activity of circRNAs was
challenged since solely 12% of circRNAs appear to have
miRNA binding sites (Ragan et al., 2019; Xu and Zhang,
2021). Additionally, other than ciRS-7, most circRNAs
do not harbor more miRNA binding sites than would be
expected by chance (Guo et al., 2014). Conversely, some
studies documented that circRNAs with a limited number
of miRNA binding sites have the ability to act as a miRNA
sponge (Tang et al., 2019). Dodbele and Mutlu proposed
that a scarce circRNA with a single miRNA binding site
is unlikely to sponge miRNAs (Dodbele et al., 2021). In
fact, the vast majority of studies about circRNA:miRNA
sponging neglects the stoichiometry between miRNAs
and circRNAs. For example, the use of circRNA
overexpression plasmids and reporter constructs create
non-physiological conditions that need to be strictly
confirmed by examining endogenous miRNA:circRNA
interactions (Dodbele et al., 2021).
RBPs interact with and modulate the fate of RNAs
by forming ribonucleoprotein complexes. Similar to
sequestration of miRNAs, circRNAs may act as protein
scaffolds, decoys, sponges, and recruiters. In recent years,
a plenty of circRNAs have been shown to interact with
proteins through specific binding sites. Apparently, the
circRNA:RBP interactions are dictated by the primary
sequence information and the unique tertiary structure
of circRNAs (Huang et al., 2020). The circRNA:RBP
interaction is a double-edged sword. As the function
of a RBP may be modulated by the circRNA, such an
interaction may result in the modulation of circRNA
biogenesis or function. In 2014, Ashwell-Fluss et al.
reported that the excess amount of MBL protein promotes
circMbl biogenesis and circMbl in turn serves as a sponge
for redundant MBL proteins (Ashwal-Fluss et al., 2014).
circMbl biogenesis is terminated upon the decline in the
MBL protein level, and the splicing machinery switches
to the production of the MBL mRNA. Multiple circRNAs
can also target one protein, such as IGF2BP3, associated
with 34 circRNAs (Schneider et al., 2016). Moreover, some
circRNAs have been reported to encode proteins through
internal ribosomal entry site-dependent and m6A-

17

TÜNCEL et al. / Turk J Biol

Figure 3. Schematic representation of circRNA biogenesis and mode of actions. (A) Two proposed models of circRNA formation.
In lariat-driven circRNA biogenesis, exon-skipping leads to an alternative form of linear RNA and a lariat, which undergoes backsplicing to form a circRNA. In direct backsplicing circRNA biogenesis, flanking inverted repeats or trans-acting factor-mediated base
pairing facilitates circRNA production. (B) Five modes of action of circRNAs: (1) circRNAs can promote parental gene transcription
by interacting with RNA Pol II, (2) circRNAs might undergo m6A-mediated cap-independent translation, (3) circRNAs might encode
unique peptides, (4) circRNAs can interact with proteins and modulate their functions, (5) circRNAs can serve as miRNA sponges to
regulate the fate of target mRNA.
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induced translation mechanisms (Prats et al., 2020). For
example, circ-E-Cad encodes a unique 254 aa E-cadherin
peptide, a new ligand that activates the EGFR signalling
pathway (Gao et al., 2021). Of note, peptides generated by
circRNA have a lot of potential as therapeutic targets and
tumor biomarkers. Tumor specific nature of circRNAencoded peptides will make them an attractive anticancer
drug target (Lei et al., 2020).
3.3.4. circRNAs in apoptosis
It is unquestionably vital to understand how circRNAs
regulate apoptosis. Therefore, recent efforts have
been geared towards the discovery and functional
characterization of circRNAs that are involved in
apoptosis and associated diseases such as cancer,
neurodegenerative diseases, and cardiovascular diseases
(Lee et al., 2019). One of the first examples of apoptosisregulating circRNA, hsa_circ_000595, was reported in
2015 (Zheng et al., 2015). Hsa_circ_000595 is significantly
upregulated under hypoxic conditions and its knockdown
attenuates hypoxia-induced apoptosis of human aortic
muscle cells. A hsa_circ_000595:miR-19a regulatory
axis appears to be involved in this process. CiRS-7 is one
of the well-characterized circRNAs with more than 70
conventional binding sites for miR-7 (Hansen et al., 2013).
Overexpression of ciRS-7 increases caspase-3 activity
and the rate of apoptosis in cardiomyocytes. Mechanistic
investigations demonstrated that Cdr1as acts as a miR7a sponge by inhibiting the regulation of miR-7a on its
targets PARP1 and SP1. Nevertheless, PARP and SP1
were invincibly upregulated and, myocardial infarction
development was elevated through ciRS-7 overexpression
with aggravated cardiac infarct size (Geng et al., 2016).
Few months later, circANRIL was reported as a regulator
of rRNA maturation process and atherosclerosis in
human (Holdt et al., 2016). circANRIL activates p53
and triggers apoptosis by impairing rRNA biogenesis. In
particular, circANRIL binds the carboxy terminal domain
of pescadillo homologue 1 (PES1) protein. Entrapment
of PES1 by circANRIL disrupts rRNA:PES1 interaction,
resulting in impaired rRNA biogenesis (Holdt et al.,
2016). circRAR1 was reported as a positive regulator of
lead-induced neurotoxicity through interacting with antiapoptotic miR-671, which targets caspase-8 and p38 (Nan
et al., 2017). Besides, a positive regulatory relationship
between circRAR1 and lncRNA RPA is documented as
one of the first examples of a regulatory interaction that
modulates neural apoptosis through a circRNA-lncRNAmiRNA axis (Nan et al., 2017). circFOXO3, which is a proapoptotic circRNA (Du et al., 2017), has a strong tendency
to bind MDM2, resulting in the release of FOXO3 from
MDM2. The released FOXO3 promotes apoptosis
by upregulating Puma expression while MDM2:p53

interactions modulate polyubiquitination of p53 (Du et
al., 2017).
There are 22 publicly available and comprehensive
circRNA databases that are maintained up-to-date
(Tang et al., 2020). Three of those, circBase, Circ2traits,
and circFunBase, are widely used in the circRNA field.
LncDisease, circFunBase, and CircR2 are the databases
that house the experimentally validated circRNAs. Table
4 summarizes the circRNAs that are associated with
apoptosis.
3.4. Long noncoding RNAs
3.4.1. Characteristics of long noncoding RNAs
lncRNAs are a class of ncRNAs longer than 300 nucleotides
in length and lack the ability to encode a protein (Costa,
2007). Similar to mRNAs, lncRNAs are transcribed by
RNA polymerase II and may contain a 5’-cap and a poly(A)
tail. Although having similar biochemical properties with
mRNAs, lncRNAs exhibit low expression levels in the cell
and are relatively poorly conserved (Statello et al., 2020).
Based on their genomic position, lncRNAs can be classified
as antisense (overlaps with antisense strand of protein
coding gene), intronic (transcribed from intron of protein
coding gene), bidirectional (bidirectional transcription
of protein coding gene), intergenic lncRNAs (localized
between two protein coding genes) and enhancer RNAs
(eRNAs) (Fernandes et al., 2019) (Figure 4A).
The science community primarily focused on studies
on the differential expression of protein-coding genes in
the early 1980s. At the end of the decade, the findings
on genomic imprinting were embraced with great
excitement and led to the discovery of the first lncRNA
H19 (Bartolomei et al., 1991). Transcribed by RNA pol
II with a small open reading frame and a poly(A) tail,
H19 was initially categorized as a mRNA. Concurrently,
the cytoplasmically localized H19 was shown not to be
associated with the translational machinery (Brannan et
al., 1990), priming the initiatives to explore the existence
of other lncRNAs with biological functions. Indeed,
the discovery of Xist, and its functions on silencing the
whole X chromosome, were a pioneering study for the
identification and characterization of lncRNAs that
emerged in 2000s upon the completion of the Human
Genome Project (HGP) (Penny et al., 1996). Further
studies have shown that lncRNAs originate from
transposable element exaptation or duplication of already
existing lncRNAs. Additionally, some lncRNAs may stem
from pseudogenization of protein coding genes due to
deleterious mutations, which results in the loss of their
translation ability (Marques and Ponting, 2014).
Earlier studies have questioned the functionality of
lncRNAs, arguing that lncRNAs could be transcriptional
noise (Costa 2007). However subsequent studies have
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Table 4. CircRNAs in apoptosis.
Disease
circRNA
Age-related cataract
circHIPK3
(ARC)
Aortic aneursym
hsa_circ_000595
Atherosclerosis

circANRIL

Atherosclerosis (AS) circRSF1
Breast cancer

hsa_circ_0001982

Breast Cancer

hsa_circ_0001098

Cardiac senescence

circ-Foxo3

Chronic obstructive
hsa_circ_0006872
pulmonary disease
Colorectal cancer
hsa_circ_0007534

Tissue/Cell line

Regulation Targeted member

References

HLECs

Down

miR-193a/CRYAA

(Liu et al., 2018)

Aortic tissues/V-SMC-6110
EC, SMC and adventitial
fibroblasts (FB), HEK-293

Up

miR-19a

(Zheng et al., 2015)

Down

PES1

(Holdt et al., 2016)

HUVECs

Down

miR-135b-5p/
HDAC1

(Zhang et al., 2021)

miR-143

(Tang et al., 2017)

miR-3942

(Zhao et al., 2018)

MDM2/P53

(Du et al., 2017)
(Xue et al., 2021)

MDA-MB-231, MCF-7,
MDA-MB-468,
Up
MDA-MB-435s and HBL-100
MCF-7
Up
MDA-MB-231 4T1 66C14,
MB-468, and MB-231
HPMECs and BEAS-2B

Up

miR-145-5p/NF-κB

CRC cells

Up

circ-ZFR

GC cells

Down

Gastric cancer

hsa_circ_0067997

Up

miR-515-5p/XIAP

(Zhang et al., 2019)

Intervertebral disc
degeneration

circVMA21/hsa_
circ_0091702

GC and corresponding
non-cancer tissues/GSE-1,
SGC-7901, MGC-803,
BGC-823 and MKN28

(Zhang et al., 2018)
miR-130a/miR-107/
(Liu et al., 2018)
PTEN

NP cells

Down

miR-200c-XIAP

(Cheng et al., 2018)

Intervertebral disc
degeneration

circERCC2

Down

miR-182-5p

(Xie et al., 2019)

Lead-induced
neurotoxicity

Nucleus pulposus (NP)
tissues /(TBHP) stimulated
NP cells (NPCs)

circRAR1

Brain tissues of mice

Up

miR-671

(Nan et al., 2017)

Lung cancer

circUBAP2

A549

Up

miR-339-5p, miR96-3p and miR135b-3p

(Yin et al., 2017)

cdr1as or ciRS-7

MCM

Up

miR-7a

(Geng et al., 2016)

hsa_circ_0043256

NSCLC

Up

miR-1252/ITCH

(Tian et al., 2017)

circ_0014130

H1299 and A549 and
BEAS-2B

Up

miR-142-5p/IGF-1

(Wang et al., 2020)

OSCC cells

Down

miR‑196a‑5p/BIRC3 (Wang et al., 2018)

Cartilage samples/SW1353

Down

miR-26a

OS cells

Up

OS cells

Up

Gastric cancer

Myocardial
infarction (MI)
Non-small cell lung
cancer
Non-small cell lung
cancer (NSCLC)
Oral squamous cell
carcinoma
Osteoarthritis (OA)

Osteosarcoma

circDOCK1/hsa_
circ_100721
circRNA-9119
circ-NT5C2/hsa_
circ_0092509
hsa_circ_0009910

Osteosarcoma

hsa_circ_0001564

HOS and MG-63 cells

Osteosarcoma

circ_0000285

hFOB 1.19, SJSA1 and U2OS

Prostate cancer
Spinal cord injury
(SCI)

hsa_circ_0001445

PCa

Up

circ-HIPK3

AGE1.HN, PC12

Down

Osteosarcoma
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(Chen et al., 2020)
(Liu et al., 2017)

miR-449a/ IL6R

(Deng et al., 2018)

Up

miR-29c-3p

(Song and Li 2018)

Up

miR-409-3p

(Long et al., 2020)
(Kong et al., 2017)

miR-558/DPYSL5

(Zhao et al., 2020)
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shown that they are evolutionarily conserved (Necsulea
et al., 2014). Although the extent of conservation among
lncRNAs is not quite to that of mRNAs, the promoter
regions of lncRNAs are particularly conserved (Pang et
al., 2006). Additionally, it is reported that transposable
elements can contribute new sequence elements to the
conserved lncRNAs throughout the evolutionary process
(Hezroni et al., 2015). According to the up-to-date
annotation of the GENCODE Project, the human genome
consists of 60,880 genes including 17,957 lncRNAs and
19,954 protein coding genes (Frankish et al., 2021). The
number of annotated genes may increase through the
discoveries of new features and extension of annotation of
alternatively spliced transcripts of lncRNAs and protein
coding genes.
3.4.2. Biogenesis of lncRNAs
Even though the global features of lncRNAs and mRNAs
suggest they have similar biochemical properties in
common, lncRNAs contain fewer and longer exons than
mRNAs. Additionally, they tend to localize primarily in
the nucleus and show lower expression patterns (Hezroni
et al., 2015). Recent studies have shown that the relatively
less abundance of lncRNAs is related to their mode of
transcription. Since the lncRNA gene promoters harbor
repressive histone modifications, they present a low
expression pattern (Lagarde et al., 2017). Apparently,
lincRNAs have relatively weaker co-transcriptional
splicing and poly(A) signal-independent Pol II
termination. This situation is followed up by accumulation
of lncRNAs on chromatin and their degradation by RNA
exosome. The functional lincRNAs mostly escape from
the nuclear surveillance process to accumulate at specific
cell types (Schlackow et al., 2017).
In contrast to the lincRNAs targeted by nuclear
surveillance process, chromatin-tethered lncRNAs may
comprise a specifically high number of U1 small nuclear
RNA binding sites (Yin et al., 2020). U1 small nuclear
ribonucleoprotein interacts with RNA polymerase
II and binds to chromatin at specific loci that leads
to accumulation of chromatin-tethered lncRNAs.
Additionally, accumulated lncRNAs sequester the action
of Pol II-associated elongation factor SPT6 (Yin et al.,
2020). Additionally, weak-splicing profile of lncRNAs
is associated with having long distance between branch
point and 3’ splice site and weak internal splicing signals
(Melé et al., 2017).
lncRNAs are found dispersed through nucleus,
nucleolus, cytoplasm, and mitochondria. The enrichment
of lncRNAs at specific cellular compartments may
determine their mode of action. RNA-seq analysis of
various human tissues showed the enrichment of lncRNAs
in the nucleus, specifically associated with chromatin

in several cell lines (Derrien et al., 2012). Subsequent
microarray analysis of K562 human myelogenous
leukemia cell line demonstrated the localization of fiftyfour percent of expressed lncRNAs in the cytoplasm.
The majority of lncRNAs in the cytoplasm are found
in polysome fractions and play a role in the control of
mRNA stability and translation (Carlevaro-Fita et al.,
2016). PYCARD-AS1 is a quintessence of lncRNAs
which function at different subcellular localizations
with specific functions. PYCARD-AS1 is an antisense
lncRNA to PYCARD, a pro-apoptotic gene (Miao et
al., 2019). PYCARD contains N-terminal PYD domain
and C-terminal Caspase recruitment domain (CARD).
PYCARD-AS1 exerts functions in regulation of intrinsic
and extrinsic pathways of apoptosis through localizing in
the nucleus or cytoplasm (Ohtsuka et al., 2004). PYCARDAS1 inhibits transcription of PYCARD via epigenetic
regulation and inhibits PYCARD-regulated apoptosis
in nuclei while PYCARD-AS1 interferes with PYCARD
mRNA and prevents its translation in the cytoplasm
(Miao et al., 2019).
3.4.3. Mode of action of lncRNAs
lncRNAs can be classified based on their functions as
molecular signals, decoys, guides, and scaffolds (Gao et
al., 2020). lncRNAs, which are transcribed in response
to a specific stimulus, are described as molecular signals
(Figure 4B). This type of lncRNAs may modulate the
transcription of downstream genes themselves or in
conjunction with transcription factors. One of the wellknown examples of a molecular signal is lincRNA-p21,
which is regulated by p53 upon DNA damage. The binding
of p53 to the CDKN1A locus activates the transcription
of CDKN1A and some other lncRNAs, lincRNA-p21
and PANDA. lincRNA-p21 mediates the p53-dependent
gene repression by recruiting heterogeneous nuclear
ribonucleoprotein K (hnRNP-K), and this interaction
triggers p53-dependent apoptosis (Hung et al., 2011).
Certain lncRNAs act as decoys by directly binding the
transcriptional regulators and impairing their functions
or hindering the binding of transcriptional factors to the
genomic DNA (Balas and Johnson, 2018) (Figure 4B). For
example, NF-YA, a nuclear transcription factor, activates
apoptosis-related genes. p53-induced PANDA lncRNA in
turn binds to NF-YA and suppresses the expression of proapoptotic genes such as CCNB1, FAS, PUMA and NOXA
(Hung et al., 2011). Additionally, lncRNAs may serve as
endogenous competitors of RNAs (ceRNAs) or miRNA
sponges as part of post-transcriptional gene regulation.
As stated previously, miRNAs bind to the 3’ UTR of target
mRNAs and micromanage their expression. lncRNAs
compete with mRNAs for binding to miRNAs, resulting
in interference with miRNA:mRNA interactions (Alkan
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Figure 4. lncRNA classification and mode of action. (A) lncRNA classification. lncRNAs are classified, based on their genomic
position, as intergenic, intronic, antisense, bidirectional and enhancer RNA. Intergenic lncRNAs are localized between two protein
coding genes and transcribed from intergenic regions, while intronic lncRNAs are processed from introns of protein coding genes.
Antisense lncRNAs are transcribed from the complementary strand of a protein coding gene. Bidirectional lncRNAs are transcribed
from both stands, and enhancer RNAs are transcribed from enhancer regions. (B) lncRNA mode of action. lncRNAs act as molecular
guides, scaffolds, signals, and decoys in cell. lncRNAs mediate the recruitment of chromatin modifiers to modulate gene expression of
target gene expression and chromatin dynamics as molecular guides. lncRNAs can direct the assembly of protein complexes to target
genes as molecular scaffolds. lncRNAs are transcribed as response to specific stimuli and work in a cooperation with transcription
factors to regulate transcription of downstream genes as molecular signals. lncRNAs function as molecular decoys by blocking
transcriptional regulators.

and Akgül, 2022). lncRNA:miRNA sponge mechanism
also can be classified as decoy mechanism. For example,
OIP5-AS1 lncRNA sponges miR-216a-5p, resulting in derepression of the GLO1 mRNA (Wu et al., 2021).
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Genome structure and organization is achieved
by an intricate folding of the genomic DNA mediated
by numerous DNA:protein interactions. As a third
mechanism, lncRNAs can act as guiding molecules
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to recruit chromatin modifiers, ribonucleoprotein
complexes and transcription factors to the target sites
to modulate chromatin dynamics and gene expression
(Wang and Chang, 2011) (Figure 4B). lncRNA HOTAIR
is one of the typical examples of guide lncRNAs. The
two ends of lncRNA HOTAIR interact with different
histone modification complexes and promote histone
methylation/demethylation of target genes. The 5’-end
domains of HOTAIR interacts with Polycomb repressive
complex 2 (PRC2). This interaction augments histone H3
lysine 27 methylation (Gupta et al., 2010). On the other
side, the 3’-end domain of lncRNA HOTAIR binds LSD1/
CoREST/REST complex and, this interaction promotes
demethylation at H3 lysine 4 residues (Tsai et al., 2010). In
addition to acting as guide molecules, lncRNAs may also
mediate the assembly of protein complexes by serving as
scaffolding molecules (He et al., 2019) (Figure 4B). A study
in human aortic smooth muscle cells (HASMC) showed
that the ANRIL lncRNA acts as a molecular scaffold for
the binding of WDR5 and HDAC3 proteins. The resulting
WDR5/HDAC3 complex activates the transcription of
NOX1 (NADPH oxidase) by deacetylation (Zhang et al.,
2020).
By using the molecular mechanisms, lncRNAs modulate
gene expression at epigenetic, transcriptional, and posttranscriptional levels (Gao et al., 2020). lncRNAs take part
in epigenetic mechanisms by interacting with chromatinmodifying enzymes and remodelling complexes. As such,
lncRNAs can either promote or prevent the recruitment
of chromatin modifiers/remodelers (Zhang et al., 2019).
For example, while Xist promotes the recruitment of
components of PRC2 and induces heterochromatin
formation by H3K27me3 deposition, lncPRESS1 interacts
with SIRT6, a histone deacetyltransferase, and inhibits
SIRT6 function, thereby causing activation of transcription
at pluripotency gene promoters (Jain et al., 2016). The
interaction of lncRNAs with DNA methyltransferases
(DNMT) changes gene expression at chromatin loci. As
an example, DBCCR1-003 lncRNA binds to DNMT1
and blocks the methylation of DBCCR1 by DNMT1
in bladder cancer cells (Qi et al., 2016). Furthermore,
lncRNAs can regulate gene expression transcriptionally
by recruiting or sequestering the regulatory protein
complexes in cis- or in trans. To this extent, lncRNAs may
directly interact with transcription factors and can change
gene expression. For instance, MALAT1 recruits the Sp1
transcription factor to the LTBP3 promoter to activate the
transcription of LTBP3 (Li et al., 2014). Lastly, lncRNAs
may interact with RBPs to regulate gene expression posttranscriptionally. As such, mRNA stability, translation,
splicing and subcellular localization may be modulated
by lncRNAs (He et al., 2019). For example, the lncRNA

pTENpg1 post-transcriptionally regulates the tumour
suppressor gene PTEN, which plays an essential role in the
maintenance of cell homeostasis as a negative regulator of
the PI3K-Akt pathway (Xing 2010). PTENpg1 regulates
PTEN by sequestering the miRNA that binds to the 3’
UTR of PTEN (Poliseno et al., 2010).
3.4.5. lncRNAs in apoptosis
lncRNAs may regulate apoptosis by modulating the
activity of transcription factors, histone modification
complexes and miRNAs or by altering the stability of
apoptosis-related proteins (Takeiwa et al., 2021). Initial
efforts were geared towards uncovering lncRNAs that
modulate apoptosis and/or proliferation in cancer cells.
For example, linc-p21 was documented to activate
p53 and apoptosis upon DNA damage (Huarte et al.,
2010). The SPRY4-IY1 lncRNA was reported to regulate
apoptosis in the LOX-IMX1 melanoma cells (Khaitan et
al., 2011). The lnc-CCNL1-3:1 lncRNA is upregulated
in polycystic ovary syndrome (PCOS) patients. The use
of a RPIseq algorithm-based prediction tool suggested
a potential interaction between FOXO1 and lncCCNL1-3:1 (Huang et al., 2021). Rescue experiments
showed that knockdown of FOXO1 attenuates the effects
of CCNL overexpression on cell apoptosis (Huang et al.,
2021). Apparently, a specific interaction between this
lncRNA and FOXO1 is essential for the nuclear retention
of FOXO1 and corresponding apoptosis. In another study,
a transcriptomics profiling study showed the expression
of as many as 10,214 differently expressed lncRNAs under
apoptotic conditions induced by cisplatin (Gurer et al.,
2021). These studies suggest that lncRNAs may modulate
apoptosis in a pathway-dependent manner.
lncRNAs may regulate the intrinsic pathway of
apoptosis by activating p53 or regulating the downstream
target genes of intrinsic pathways such as Bcl-2 family
members (Shi et al., 2018; Wu et al., 2020). Taurine up
regulated 1 lncRNA (TUG1) modulates apoptosis by
regulating different target genes in different cell types (Liu
et al., 2017; Long et al., 2018). A study reported that a
direct interaction between EZH2 and TUG1 alleviates the
expression level of pro-apoptotic BAX in lung cancer cells
(Liu et al., 2017). Another study showed the oncogenic
role of TUG1 by enhancing the astrocyte elevated gene1 (AEG1) expression by sponging miR-129-5p in human
malignant melanoma. Activation of this regulatory axis
leads to an increase in the rate of apoptosis through
downregulation of Bcl-2 and upregulation of cleaved
caspase -3 in TUG1-suppressed melanoma cells (Long et
al., 2018).
Urothelial cancer associated 1 (UCA1) is a lncRNA
upregulated in bladder cancer cells. Studies showed that
binding of Ets-2, a transcription factor that binds to the
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UCA1 promoter, modulates its transcription (Wu et al.,
2013). Ets-2 transcriptionally regulates UCA1, resulting
in activation of the Akt signalling pathway and suppresses
the bladder cancer cell apoptosis (Wu et al., 2013). Despite
the presence of high levels of endoplasmic reticulum (ER)
stress in cancer cells, the mechanism of how cancer cells
evade apoptosis under these conditions is not elucidated
completely (Rozpedek et al., 2016). It was shown that
golgin A2 pseudogene 10 (GOLGA2P10) lncRNA protects
hepatocellular carcinoma cancer (HCC) cells from ERstress-induced apoptosis by modulating the intrinsic
pathway. An increase in transcription of GOLGA2P10 via
ER-stress inducers leads to the induction of PERK/ATF4/
CHOP signalling pathway. Mechanistically, GOLGA2P10
interferes with the ER-stress-induced apoptosis by
modulating BCL-xL and phosphorylated-BAD levels in
HCC cells (Wu et al., 2020).
Regulation of the extrinsic apoptotic pathway can
be mediated directly or indirectly by lncRNAs (Jiang et
al., 2021). For example, alternatively spliced soluble Fas
receptor (sFas) that exclude exon 6 leads to inhibition
of apoptosis by interfering Fas ligand (FasL) (Bonnal et
al., 2008). The regulation of alternative splicing of Fas is
achieved by lncRNA antisense transcript of Fas (FAS-AS1)
in lymphomas. FAS-AS1 binding to RBM5 inhibits the
exon 6 skipping in alternative splicing mediated by RBM5
and production of sFAS. Subsequent studies showed
that hyper-methylation of FAS-AS1 by EZH2 causes the
production of sFas in lymphomas and sequestration of
apoptosis by sFas (Sehgal et al., 2014). HOX antisense
lincRNA HOXA-AS2 is upregulated upon ATRA (all
trans retinoic acid) treatment in NB4 cell line (Zhao et
al., 2013). ATRA-treated HOXA-AS1 knockdown cells
exhibited enhanced caspase-3, 8, -9 activities and BAX
levels. Subsequent studies uncovered that TRAIL levels
were upregulated, and application of TRAIL-neutralizing
antibody partially suppressed caspase-8 and -9 activities
in ATRA-treated HOXA-AS1 knockdown cells. Overall,
HOXA-AS1 acts as a repressor of apoptosis and TRAIL
may be partially involved in this regulatory mechanism
in ATRA-treated NB4 promyelocytic leukemia cells
(Zhao et al., 2013). Despite the potential use of TRAIL
as a chemotherapeutic target, recent reports show the
emergence of resistance of pancreatic cancer cells to
TRAIL-induced apoptosis (James and Griffith, 2014).
HOTAIR is expressed at low levels in cells sensitive to the
TRAIL-induced apoptosis while it exhibits high expression
level in the resistant cells. Apparently, the sensitivity of
pancreatic cells is correlated with the HOTAIR expression
level (Yang et al., 2017). HOTAIR overexpression results
in the inhibition of death receptor 5 (DR5) by EZH2mediated trimethylation of the lysine residue of histone 3
around the DR5 promoter (Yang et al., 2017).
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lncRNAs may target tumour suppressor genes such
as p53 and PTEN to control apoptosis (Levine and Oren,
2009; Yamada and Araki, 2001). For example, lncRNAGas5 binds to miR-103 and sequesters it away from
PTEN. This interaction enhances the expression of PTEN
and promotes apoptosis in endometrial cancer cells
(Guo et al., 2015). On the other hand, if lncRNA-GAS5
binds to the DNA binding domain of glucocorticoid
receptor (GR), it blocks the interaction between GR and
glucocorticoid response element (GRE). By serving as a
decoy for GRE, lncRNA-GAS5 blocks the transcription
of GR and neutralizes the anti-apoptotic effects of GR,
sensitizing cells to apoptosis (Kino et al., 2010). MEG3
activates p53 by downregulating its negative regulator,
MDM2. The underlying mechanism of downregulation
of MDM2 expression by MEG3 is not clear yet (Zhou et
al., 2007). With respect to apoptosis, transactivation of
p53 by MEG3 increases caspase 3 expression levels and
decreases Bcl-2 and Cyclin D1. MEG3 promotes apoptosis
and inhibits proliferation by activation of p53 in human
osteosarcoma cells (Shi et al., 2018).
3.4.6. lncRNA databases
Advances in transcriptome-wide studies have led to
the establishment of lncRNA databases to maintain the
resulting massive data (Fritah et al., 2014).The most widely
used databases include LNCipedia (Volders et al., 2019),
LncDisease (Bao et al., 2019) and lncRNAdb (Amaral
et al., 2011) as they house the experimentally validated
interaction of lncRNAs with other macromolecules.
Databases such as DIANA-LncBase (Wang et al., 2016)
and TargetScan (Agarwal et al., 2015) may be used to
predict putative lncRNA-miRNA interactions. Based on
the lncRNA-Disease database, we listed the lncRNAs
with experimentally validated functions in apoptosis of
different cancer cells in Table 5 (Bao et al., 2019).
4. Conclusion
Apoptosis is a complex cellular mechanism that plays a
critical role in the maintenance of organismal homeostasis
throughout development. Undoubtedly, apoptosis
is regulated by epigenetic, transcriptional and posttranscriptional gene regulatory mechanisms mediated
by protein coding genes. The accumulating evidence
demonstrates that these regulatory proteins are regulated
by a diverse biotype of ncRNAs, ranging from miRNAs
to lncRNAs and circRNAs. It is important to underline
the existence of other types of ncRNAs, such as piRNAs
or tRNA-derived fragments (tRF) that are known to be
involved in apoptotic processes (Cosacak et al., 2018;
Zeng et al., 2020). More excitingly, the emerging studies
document an intricate interplay among various ncRNAs
(Patop et al., 2019; Rong et al., 2017). For example, a
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Table 5. LncRNAs in apoptosis.
Targeted
member
RBM5

Disease

lncRNA

Tissue/Cell line

Regulation

B cell lymphoma

FAS-AS1

Granta-519 cells

Down

Bladder cancer

ANRIL

T24 and EJ cells

Up

Bladder cancer

GAS5

T24 and EJ cells

Down

EZH2

(Wang et al., 2018)

Bladder cancer

UCA1

Up

Ets-2

Breast Cancer

GAS5

(Wu et al., 2013)
(Pickard and Williams,
2016)

Breast cancer

OIP5-AS1

BLZ-211 and BLS-211 cells
MCF7, T-47D and
MDA-MB-231 cells
MCF-10A,SK-BR-3
and MDA-MB-231

GAS5

HeLa and HCT116 cells

Abundant

HOTAIR

SiHa, HeLa, Caski, c4-1 cells

Up

LINP1

Hela S3, SiHa and Hela cells

Up

(Wang et al., 2018)

Up

(Xu et al., 2017)

Up

(Niu et al., 2016)

Up

(Sun et al., 2016)

Cervical & colon
cancer
Cervical cancer
Cervical cancer

Cholangiocarcinoma UCA1
Colorectal adenoma

AK027294

Colorectal cancer
Diabetic
Cardiomyopathies

DQ786243

CCLP1 and RBE cells
HCT116, HCT8, and SW480
cells
SW620 and HT29 cells

H19

Diabetic rat tissue/HEK293 cells Down

Diabetic
nephropathy

PVT1

Endometrial cancer

GAS5

Gastric cancer

AC113133.1

Gastric cancer

BANCR

Gastric cancer

MEG3

Gastric cancer

MEG3

Glioma

CRNDE

Glioma

EGOT

Glioma

ANCR

The immortalized mouse
podocyte cell line mouse
podocyte clone 5 (MPC5),
patient samples, mice sections
HHUA and JEC cells
HGC-27, AGS, and
SGC-7901 cells
BGC-823 and MGC-803 cells
HGC-27,BGC-823
and GES-1 cells
MGC-803, HGC-27,
MKN-45, SGC-7901,
BGC-823 and AGS cells
GSC-U87 and GSC-U251 cells

(Li et al., 2016)

Up

FOXA1

(Liu et al., 2019)

Down

miR-103
(Guo et al., 2015)
PI3K/Akt
(Huang et al., 2017)
pathway
NF-κB1/miR-9. (Zhang et al., 2015)

Up
Up
Down

miR-181a

(Peng et al., 2015)

Up

miR-186

(Zheng et al., 2015)

FTX

Mice cardiomyocytes

Down

Lung cancer

lncFOXO1

A549, H460, HCC827 and
H1299 cells

Down

Lung cancer

TUG1

SPC-A1 and H1299 cell lines

Up

Lung carcinoma

Lnc_bc060912 H1299, A549 and 293T cells

Up

PDIA3P1

Malignant melanoma TUG1

(Jiao and Zhang, 2019)

Down

Down

GOLGA2P10

miR-216a-5p/
(Wu et al., 2021)
GLO1
Glucocorticoid
(Kino et al., 2010)
receptor
miR-143-3p
(Liu et al., 2018)

miR-675

U251 and U87 cells
U87, U251, SHG44, and U118
cells
MHCC-97H, QGY-7703,
SK-HEP-1 and 293T cells
HepG2, HCCLM3, Huh7,
SMMC-7721, and SK-Hep1 cells

Hepatocellular
carcinoma
Hepatocellular
carcinoma
Ischemia/
reperfusion injury

(Sehgal et al., 2014)
(Zhu et al., 2015)

Up
Up

References

(Wu et al., 2017)

Up

EZH2

Up

PERK/ATF4/
(Wu et al., 2020)
CHOP pathway

Up

p53 pathway

HEMa-LP, A375, WM35, SKUp
MEL-5, and SK-MEL-2 cell lines

miR-29b-1-5p
and Bcl2l2
PI3K/AKT
signaling
pathway
BAX and EXH2
PARP1 and
NPM1
miR-129-5p

(Cheng et al., 2020)

(Kong et al., 2017)
(Long et al., 2018)
(Ding et al., 2018)
(Liu et al., 2017)
Luo et al., 2015
(Long et al., 2018)
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Table 5. Continued.
Disease

lncRNA

Tissue/Cell line

Regulation

References

Myocardial I/R

H19

Mouse Model of Myocardial
I/RI

Targeted
member

Down

miR-877-3p

(Li et al., 2016)

LOC401317

HNE2, HNE1, and CNE2 cells

Up (After p53
p53
overexpression)

(Gong et al., 2014)

ANRIL

CNE2 and HONE1 cells

Up

(Hu et al., 2017)

HULC

SUNE and CNE-1 cells

Up

lincRNA-p21

A549, H1299, H1650, and
NCI-H2087 cells

Up

PUMA

(Yang et al., 2019)

TRPM2-AS

A549 and H1299 cell lines

Up

SHC1

(Ma et al., 2017)

Up

miR-874

(Yang et al., 2017)

Down

NF-YA

(Han et al., 2015)

Nasopharyngeal
carcinoma
Nasopharyngeal
carcinoma
Nasopharyngeal
carcinoma
Non-small cell lung
cancer
Non–small cell lung
cancer
Non–small cell lung
cancer
Non-small cell lung
cancer
Osteosarcoma

XLOC_008466 A549 and H460 cells
PANDAR
MEG3

Pancreatic cancer

HOTAIR

Pancreatic ductal
adenocarcinoma

FEZF1-AS1

A549, SPC-A1 and NCI-H1299
and SK-MES-1
MG63 cells
BxPC3, MiaPaCa-2, Suit2, and
PANC-1

Parkinson’s disease
Polycystic ovary
syndrome

NEAT1

Preeclampsia

MEG3

Premature ovarian
insufficiency (POI)

HTR-8/SVneo, JEG-3, human
amniotic epithelial cells (WISH),
Down
and human umbilical vein
endothelial cells (HUVEC)

PVT1

Granulosa cells and POI tissues

Prostate cancer

PCAT-1

Prostate cancer

SOCS2-AS1

Rheumatoid arthritis MALAT1

(Jiang and Liu, 2017)

Down
p53
Down
(sensitive) / Up DR5
(resistant)

PANC-1, Capan-2, MIAPaCa-2,
SW1990, and BxPC-3 and
Up
HPDE6-C7 cells
SH-SY5Y cells and mice models Up

lnc-CCNL1-3:1 hLGCs

miR-125a

Up

Down

PC3, DU145, LNCap and C4-2
Up
cells
LNCaP, VCaP and their LTAD
Up
cells
Rheumatoid arthritis fibroblastUp
like synoviocytes (RAFLS)

miR-107

(Shi et al., 2018)
(Yang et al., 2017)
(Ye et al., 2018)

miR-124/KLF4 (Liu et al., 2020)
FOXO1

(Huang et al., 2021)
(Zhang et al., 2015)

Foxo3a

(Wang et al., 2021)

miR-145-5p

(Xu et al., 2017)
(Misawa et al., 2016)
(Pan et al., 2016)

T-cell acute
lymphoblastic
leukemia

T-ALL-RLncR1

Jurkat cells

Up

Par-4

Urinary bladder
cancer

lincRNA
AATBC

UM-UC-3 and EJ bladder
cancer cells

Up

JNK and NRF2
signaling
(Zhao et al., 2014)
pathways

circRNA may serve as a sponge for a miRNA, which
may be regulating the stability of a target lncRNA that
potentially interacts with a DNA-binding protein. Thus,
it will be highly informative to uncover this complex and
dynamic network of interactions between ncRNAs and
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(Zhang et al., 2014)

other macromolecules. Additionally, a recent report on
small ncRNAs modified with N-glycans and displayed on
the surface of living cells opens a new avenue, expanding
the role of ncRNAs in extracellular biology (Flynn et al.,
2021).
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